Matšoao a "Neuro-Genetics" a Melemo ea ho Fokotsa Moputso (RDS) e le Mohloli oa "Tšebeliso ea Lithethefatsi": Phenomenon e Ncha Ka mor'a hore Bariatric Surgery (2011)

J Genet Syndr Gene Ther. 2011 ea December 23; 2012(1): S2-001. doi:  10.4172/2157-7412.S2-001

inahaneloang

Joale kamora lilemo tse ngata tsa bongaka tse atlehileng tsa bariatric (ho theola boima ba 'mele) tse lebisitsoeng ho baoki ba mafu a seoa sa botenya li tlaleha hore bakuli ba bang ba nkela khatello e fetelletseng ka mathata a sa tsoa fumanoa a joalo ka bokhoba ba tahi, ho becha, lithethefatsi le litlatsetso tse ling tse kang ho reka ka thata le ho ikoetlisa. Sengoloa sena sa tlhahlobo se hlahloba bopaki bo tsoang lipatlisisong tsa lefutso la mafu a kelello le lithuto tsa batho tse hokahanyang ho nona ho tlola tekano le mafu a mang a phehellang ho hlalosa mohopolo oa phetisetso ea tlhekefetso. Mohlomong ka lebaka la ho ts'oana ho amanang le methapo ea kutlo, ho ja ho feta tekano le botenya li ka sebetsa e le lintlha tsa ts'ireletso tse fokotsang moputso oa lithethefatsi le boits'oaro bo lemaletseng. Mehlaleng ea liphoofolo ho tlosoa ha joala ho tsoekere ho kenella ho se leka-lekaneng ho li-neurotransmitters, acetylcholine le dopamine, tse ts'oanang le ho tlohela ho ts'oanang. Liphuputso tse ngata tsa batho tsa neuroimaging li tšehelitse mohopolo oa ho hokela takatso ea lijo le boitšoaro ba ho lakatsa lithethefatsi. Pejana laboratori ea rona e ne e qapile polelo Reward Deficiency Syndrome (RDS) bakeng sa liphatsa tse tloaelehileng tsa lefutso ho bolela esale pele mafu a lemallo mme e tlaleha hore boleng ba ponelopele bakeng sa boits'oaro ba RDS lithutong tse nang le DRD2 Taq A1 allele e ne e le 74%. Le ha liphatsa tsa lefutso li bapala karolo ho RDS, re boetse re hlahisitse hore ho sitisoa hoa tšebetso ea dopamine ho ka etsa hore batho ba bang ba be le boits'oaro bo bobebe le botena. Ha joale hoa tsebahala hore nalane ea malapa ea botaoa ba joala ke ntho e kholo e ka bakang kotsi ea botenya. Ka hona, re ts'oants'a mona hore RDS ke sesosa sa ho kenyelletsa ts'oaetso ea lijo bakeng sa litlhoko tse ling mme ka mokhoa o hlalosang sena se hlalositsoeng Phenomenon (phetiso ea bokhoba) e tloaelehileng kamora ts'ebetso ea bongaka ea bariatric.

Keywords: Ho buuoa ka Bariatric, Ho fetisetsoa bokhobeng, ho mamella sefapano, lefu la moputso oa khaello, Dopamine, liphatsa tsa lefutso

Selelekela

Phekolo ea basebetsi, kapa ho buuoa ka boima ba 'mele, ho kenyelletsa mekhoa e mengata e etsoang ho batho ba batenya haholo. Ho fokotsa boima ba 'mele ho fihlelloa ka ho fokotsa boholo ba mpa ka sesebelisoa sa bongaka se kentsoeng (gastric banding) kapa ka ho tlosa karolo e itseng ea mpa (sesele gastondolaomy kapa biliopancreatic diversion ka duodenal switch) kapa ka ho hlophisa le ho pheta-pheta mala a manyane ho mokotla o monyane oa mpeng (ho buuoa ka gastric bypass). Boithuto ba nako e telele bo bonts'a lits'ebetso li baka tahlehelo e kholo ea nako e telele ea boima ba 'mele, ho hlaphoheloa ho lefu la tsoekere, ntlafatso ea mabaka a pelo le phokotseho ea ho shoa ha 23% ho tloha ho 40% [1].

Ho buuoa ka Bariatric ho etselitsoe lithuto tse nang le BMI ≥ 40 kg / m (2) kapa ≥ 35 kg / m (2) ka li-co-morbidities [2]. Kamora lilemo tse 60, lilemo tsa boikoetliso le 'mele li hloka ho tsotelloa ka hloko. Bophelong ba botona ba lefutso, ho buuoa ho bonahala ho loketse. Lits'oaetso tse ka sehloohong li kenyelletsa mathata a tebileng a ho fepa, mathata a kelello a sa tsitsitseng, bokhoba ba tahi, bokhoba ba lithethefatsi le ho sitoa ho nka karolo ho latela teko ea nako e telele ea bongaka. Ts'ebetso ea ts'ebetso ea opereishene e kenyelletsa methati e mengata ea bohlokoa: tlhahlobo le boitokisetso ba sehlopha sa machaba ho khetholla li-contraindication, fana ka thuto e nepahetseng ea pele ho ts'ebetso ea mokuli, ho hlahloba le ho phekola boitšoaro bo bobebe bo kang lefu la apnea syndrome, lefu la tsoekere le lefu la pelo le tlhahlobo ea boemo ba kelello le phepo le phepo. boits'oaro. Qeto ea ho kenella e boetse e thehiloe holim'a tlhoko ea ho latela bophelo bohle ho kenyelletsa: ho hlahlojoa ha bofokoli ba phepo e nepahetseng le mathata a ho buuoa, tlhabollo ea matlafatso ea phepo le ts'ebetso ea 'mele le ho thusa ho ikamahanya le maemo a macha (joalo ka boimana), le ho fetisetsoa tlhokomelo ea kelello ha ho hlokahala [3].

Ho latela Odam et al. [3] liphatlalatso tsa bohlokoa ba tšebetso ea boima ba 'mele ka mor'a ho buuoa ka bariatric li kenyelletsa matšoao a takatso ea lijo tsa mantlha, bophelo bo botle, le ho tšoenyeha ka boits'oaro bo bobebe. Ka hona, ha ho khethoa ho tšoaneleha bakeng sa ho buuoa ka bariatric bakeng sa bakuli ba batenya haholo, ho hlahlojoa ha kelello ho bohlokoa; hape e bohareng ba katleho ea postoperative. Half halofo ea bakuli ba sebetsanang le lingaka tsa khatello ea maikutlo ba na le khatello ea maikutlo le ho bakuli ba nang le index ea boima ba 'mele ea 40 kg / m2 kapa ho hoholo, ho na le menyetla e mehlano ea khatello ea maikutlo [4].

Fokotsa ho shoa hoa batho le ho fokolloa ke bophelo

Liphuputso tse 'maloa tsa morao-rao li tlaleha ho fokotseha ha lefu le ho teba ha maemo a bongaka ka mor'a ho buuoa ka bariatric [4-7]. Leha ho le joalo, litlamorao tsa nako e telele ha li hlake [8]. Thutong e lebelletsoeng ea Sweden e lekantsoeng, bakuli ba nang le BMI ea 34 kapa ho feta bakeng sa banna le 38 kapa ho feta bakeng sa basali ba ile ba etsoa mefuta e fapaneng ea ts'ebetso ea bariatric mme ba lateloa ka lilemo tse 11. Bakuli ba opereishene ba ne ba fokotsehile ka lefu la 23.7% (taolo ea 5.0% le 6.3%, tekanyetso ea kotsi e fetotsoeng 0.71). Sena se bolela hore bakuli ba 75 ba tlameha ho phekoloa ho qoba lefu le le leng kamora lilemo tse 11. Phuputsong e entsoeng ka utah ea cohort ea Utah e ileng ea latela bakuli ka karolelano ea lilemo tse 7 kamora mefuta e fapaneng ea ts'oaetso ea sefuba, bakuli ba buoang ba bile le lefu la 0.4% ha bakuli ba laolang ba ne ba e-na le lefu la 0.6% [6]. Leha ho le joalo, litekanyetso tsa lefu li ne li le tlase ho bakuli ba lefu la ka mpeng bakeng sa maloetse ohle a kopaneng, hammoho le lefu la tsoekere, lefu la pelo le mofets'e. Ka lehlakoreng le leng, batho ba bolaoang ka lebaka la kotsi le ho ipolaea ba ne ba phahame ka 58% sehlopheng sa lingaka tse buoang [9].

Teko e laoloang ka mokhoa o hlophisitsoeng, e laoloang Australia e ile ea bapisa banding ea laparoscopic e fetohang ("lap banding") le kalafo e sa sebetseng ho batho ba baholo ba 80 ba batenya haholo (BMI 30–35). Ka lilemo tse peli, sehlopha se phekoloang ka opereishene se ile sa fokotseha boima bo bong bo eketsehileng (2% ea boima ba 'mele bo qalang le 21.6%) mme sa ba le ntlafalo e kholo ea khatello ea mali, mehato ea taolo ea lefu la tsoekere, le high density lipoprotein cholesterol [7]. Ho etsa opereishene ea bakuli ho bakuli ba tsofetseng e bile sehlooho sa ngangisano, se shebaneng le lipelaelo tsa polokeho sechabeng sena. Phuputso e 'ngoe ea bakuli ba tsofetseng ba sebetsanang le opereishene ea laparoscopic bariatric Setsing sa Bongaka sa Mount Sinai, leha ho le joalo, e tlaleha 0% ho fetoha ts'ebetso ea ho buoa e butsoeng, 0% lefu la matsatsi a 30, sekhahla sa mathata a 7.3%, karolelano ea sepetlele ea matsatsi a 2.8 le lefu la ts'ebetso ea ts'ebetso ho tloha ho 0.1. - 2% [9]. Ho khahlisang, tekanyo ea mathata a bonahala a fokotseha ha ts'ebetso e etsoa ke ngaka e buoang e nang le boiphihlelo. Tataiso e khothaletsa hore ho etsoe opereishene ka likarolo tse inehetseng kapa tse nang le boiphihlelo [10].

Opereishene ea bariatric le boits'oaro bo lematsang

Boloetse ba botenya bo hlaha e le lefu le fokolisang ka ho fetisisa mehleng ea kajeno, hammoho le sesosa se ka sehloohong sa lefu le ka thibeloang. Bakeng sa batho ba anngoeng ke botenya bo feteletseng, ts'ebetso ea bongaka ea bariatric ke ts'ebetso e le 'ngoe e nang le ts'ebetso e netefalitsoeng bakeng sa ho fokotsa boima ba' mele ka nako e telele. Ntle le moo, liphuputso tse ngata tsa boithuto ba mahlale li bonts'a hore tahlehelo ea boima ba 'mele kamora ho buuoa ka bariatric e tsamaisana le liphetho tse ling tse ngata tse ntle, ho kenyelletsa ntlafatso e kholo ea bophelo, ho fokotsa kapa ho fetola maemo a kalafo a sa foleng a kang khatello ea mali, ho koaleha boroko le lefu la tsoekere — le ho lelefatsa. nako ea bophelo [11]. Ebile tlhahlobo ea lefu la lilemo tse 25 ho The Program on the upasuaji oa Hyperlipidemia (POSCH) e bonts'a melemo ea lipalo: ho pholoha ka kakaretso, ho pholoha ntle le lefu la pelo, le tebello ea bophelo, sehlopheng sa bongaka se bapisoang le taolo sehlopha [12]. Joale lilemo tse latelang tsa ts'ebetso e atlehileng ea ho ikoetlisa ho theola boima ba 'mele, lingaka le bafuputsi ba hlokometse hore bakuli ba bang ba khaotsa ho ja ho feta tekano mme ho e-na le hoo ba fumana mathata a macha a tlisoang ke botahoa, papali ea chelete kapa lits'ebeliso tse ling tse joalo ka ho reka ka makhetlo. Le ha ho hlahisitsoe tlhahiso ea hore bakuli ba nke mokhoa o mocha oa ho lemalla e le phapanyetsano ea bothata ba bona ba ho ja ka mokhoa o qobelloang (tlatsetso ea bokhoba ba tahi), hore na mofuta ona oa ketsahalo o etsahala hangata hakae le hore na ho na le kamano ea nnete le phello lipakeng tsa bongaka le ngaka ponahalo ea mekhoa ena ha e so thehiloe.

Ho na le nomoro ea litlaleho tsa PUBMED tse fanang ka maikutlo a hore ketsahalo ena e ncha e ntse e phahama ebile ke ea 'nete. Ho na le ho tšoana ho hongata lipakeng tsa botena le boits'oaro bo lemalloang, ho kenyelletsa liphatsa tsa lefutso, botho, maemo a kotsi ea tikoloho, le litsela tse tloaelehileng tsa kelello bokong, matšoao a ts'ebetso ea bongaka ea bariatric e le mokhoa oa kalafo bakeng sa bakuli ba boitšoaro bo bobe haholo o hloka ts'ebeliso ea mekhoa ea khetho e sebetsanang le mekhoa ea khetho tekanyo ea botenya, mathata a amanang le ona le ho hloleha ho fetileng hoa kalafo e tloaelehileng. Joala kapa bokhoba ba lithethefatsi le lefu le tebileng ke li-contraindication bakeng sa ts'ebetso ea bongaka ea bariatric [13]. Boithuto sebakeng sena bo kenyelletse ho khaotsa narcotic, tšebeliso e mpe ea joala le lithethefatsi tse ling empa lipatlisiso tse matlafatsang li hlile lia hlokahala [13-17]. Habohlokoa le ho feta, kamano e teng lipakeng tsa ho ja, ho ja ho feta tekano le ho lemalla e se e buisanoa, ho phehisanoa ka lipotso le ho sa tsoa hlahlojoa haufinyane.

Sehlopha sa Gold le ba bang ba kholoa hore lithethefatsi tsa tlhekefetso li qothisana lehlokoa le lijo tsa libaka tsa moputso oa boko [18,19]. Tlalehong ea bona mabapi le kamano e fapaneng pakeng tsa ho ba teng ha comorbid overweight / botenya le mathata a ts'ebeliso ea lithethefatsi ho bipolar I disorder, McIntyre et al. [19] liphetho li fana ka maikutlo a hore mathata a bokhoba ba comorbid (ke hore, tšebeliso ea lithethefatsi le ho nona ho tlola) a ka qothisanang lehlokoa le tsona litefiso tsa moputso oa boko.

Ho ikoalla ho feta tekano le botenya li ka sebetsa e le lintho tse sirelletsang ho fokotsa moputso oa lithethefatsi le ho lemalla joala. Thutong ea bona Kleiner et al. [20] e hlahlobile lichate tse 374 tsa bakuli bohle ba mafolofolo ba tsamaiso ea boima nakong ea likhoeli tse 12. Tlhahisoleseling ea batho, liteko tsa laboratori, tlhahlobo ea tlhahlobo ea mafu a kelello, nalane ea joala le lithethefatsi li ile tsa hlahlojoa. Ts'ebeliso e hlakileng ea tšebeliso ea joala, tlhekefetso, nalane ea ho itšetleha e ne e le teng lichate tsa 298 e le karolo ea tekolo ea pele ho bariatric. Kamano lipakeng tsa BMI le ts'ebeliso ea joala har'a bakuli ba basali (n = 298) e ile ea hlahlojoa. Ba fumane kamano ea bohlokoa (p <.05) e fapaneng lipakeng tsa BMI le ts'ebeliso ea joala. Ha mokuli a ne a nonne haholo, ba ne ba noa joala bo fokolang. Peresente ea basali ba noang joala selemong se fetileng e fokotsehile ha boemo ba BMI bo ntse bo eketseha. Liphetho tsena li netefalitse maikutlo a lingaka tsa hore ha ho bonolo ho fumana mokuli ea imetsoeng kelellong a sa kenyelletsoa kalafo ea bariatric ka lebaka la ho noa joala haholo. Sehlopha sa Khauta se fihletse qeto ea hore bakuli ba batenya ho tlola ba na le litheko tse tlase tsa ts'ebeliso ea joala ho feta tse fumanehang ho basali ka kakaretso. Ha BMI e ntse e eketseha, litekanyetso tse tlase tsa ts'ebeliso ea joala lia fumaneha. Ho ja haholo ho ka qothisana lehlokoa le joala bakeng sa libaka tsa moputso tsa boko, ho etsa hore ho noa joala ho se ke ha matlafatsa [20]. Patlisiso e 'ngoe ea Hagedorn et al. [21] o fihletse qeto ea hore metabolism ea joala e ne e fapane haholo lipakeng tsa ho fetela ka morao ho thuto le lithuto. Bakuli ba gastric bypass 'ba ne ba le joala bo phahameng haholo ba joala le nako e teletsana ea hore joala bo fihle ho 0 ho feta taolo. Liphetho tsena li fana ka tlhokomeliso mabapi le tšebeliso ea joala ke bakuli ba gastric bypass tse nang le metabolism e fetotsoeng ea joala.

Litsi tsa tlhekefetso ea lithethefatsi, ho kenyeletsoa Setsi sa Betty Ford se Rancho Mirage, Calif., Li re ba bona bakuli ba eketsehileng ba sebetsanang le lingaka tse buoang ba batla ho thusoa ka litlolo tse ncha. Tšebeliso ea joala e fetohile sehlooho sa puisano libakeng tsa ts'ehetso ea bongaka ba bariatric, joalo ka Weight Loss Surgery Center, wlscenter.com. Ka polelo e sa phatlalatsoang Setsing sa Betty Ford, ke hoo e ka bang 25% ea batho ba lemaletseng tahi ba tsubang ba fetohelang setheong se secha, joalo ka opiates. Ha e sa ntse e le phehisano, sekhahla sa ho sokolohela maemong a mang se fapana ho tloha ho 5% ho isa ho 30% [22].

Ho re thusa ho utloisisa mofuta oa mamello le phetisetso ea tlhekefetso re fana ka litlaleho tsa linyeoe ho supa ketsahalo ena e ncha e hlahang kamora ho buuoa ka bariatric.

Case Reports

Case 1

Client H o ne a le lilemo li 27, mosali e mosoeu ea kenetseng kalafo ea tlhekefetso ea polysubstance le bipolar November 2008. Lintho tseo a li khethileng e ne e le opiates (heroin), li-stimulants (Crack) le benzos (xanax). O ne a le boima ba li-lbs 135, ka bophahamo ba 61in ka foreimi e nyane, ha a fihla kalafong. O ile a kena kalafo lilemo tse peli kamora ho latela tsela ea ka mpeng.

Pele ho ts'ebetso ea bongaka, Client H e ne e le boima ba 293 lbs. O ile a lumela hore o sebelisa joala hampe le ho sebelisa matekoane ka linako tse ling pele a buuoa ka Mphalane 2006. Client H o ile a feta ka lilemo tse 25 a le ka mpeng. Kamora ho buuoa, o ile a fumana hore a ke ke a hlola a noa joala bo bongata ho hlahisa litholoana tseo a li batlang 'me a lemalla moriana oa bohloko oo a neng a o laetsoe ka lebaka la bohloko ba pelehi.

Lilemong tse peli tse latelang ka mor'a ho buuoa, o ile a tsoela pele ho tloha lipakeng tsa lingaka tse fanoang ke ngaka ho ea lithethefatsi tsa seterateng. O ile a qala ho sebelisa k'hok'heine hobane a hlokometse hore ha a na matla ka lebaka la opiates ka bobeli le khaello ea phepo e mpe e hlahisoang ke ngaka e buoang. Crack e ne e le ntšetso-pele ea tlhaho ea koae le tšebeliso ea heroin e tlatsitsoeng ebe e nkeloa opiates ea lengolo la ngaka.

Ho tloha ka Hlakubele 2010, Client H e se e le lilemo tse peli e hloekile hape e le betere. O ile a khutlela morao habeli nakong ea matsatsi a 2 kamora kalafo. Hajoale, Client H o ntse a sebelisa li-amino acid ho tsamaisa matšoao a hae a ho ferekana.

Case 2

Client M o ne a le lilemo li 47, mosali e mosoeu a kenetse kalafo ea tlhekefetso ea polysubstance, lefu la ho ferekana le khatello ea maikutlo. Lintho tseo a neng a li khetha e ne e le joala, lipilisi tsa bohloko le koae. Client M o ile a kena kalafo ka Hlakubele ea 2010 a le boima ba liponto tse 235 lilemo tse tharo (3) kamora ho buuoa ka thipa ka October 2007.

Pele a buuoa o ne a le boima ba liponto tse 285. O bile kalafo makhetlo a mahlano pele mme o lumela ho sebelisa lipilisi tsa bohloko pele a buuoa. Boima ba hae bo tlase ka mor'a ho buuoa e ne e le liponto tse 200.

Hajoale o na le likhoeli tse 10 a hloekile a hlaphohetsoe kelellong 'me o sebelisa li-amino acid ho laola matšoao a hae a ho phefumoloha le matšoenyeho.

Case 3

J ke mosali ea lilemo li 44 ea boitšoaro bo botle haholo ea nang le lefu la khatello ea mali, mofuta oa 2 lefu la tsoekere le sa tšepahaleng, ho koaleha ka boroko le khatello e tlase ea venous stasis. Nakong e fetileng o ile a kena sepetlele bakeng sa kalafo e tloaelehileng ea cellulitis mme a amohela lithibela-mafu tsa IV. O boetse o tšoeroe ke bohloko bo sa feleng ba mokokotlo le mokokotlo mme o bile le mokuli lenaneong la rona la taolo ea bohloko ka lilemo tse ngata. Ka nako ena bohloko ba hae bo se bo laoloa haholo. Tlhahlobo ea hae ea 'mele le lithuto tsa radiologic li bonts'a lefu le holofatsang la disc, lefu la arthropathy le lefu la masapo a manonyeletso. Morero oa hae oa kalafo o ne o kenyelletsa, ho fokotsa boima ba 'mele, ho ikoetlisa ka' mele le ho etsa lintho tse fapaneng. Kamora ho leka litlhare tse 'maloa tse sa amaneng le phekolo ea hae, mofuta oa hae oa phekolo o ile oa tsoela pele ho kenyelletsa kalafo ea opioid e sa foleng e fanang ka liphallelo tse leka-lekaneng le mosebetsi o ntlafalitsoeng. Mokhoa oa hae oa bongaka o ne o kenyelletsa pregabalin 75 mg TID, duloxitine 60 mg / ka letsatsi, hammoho le oxymorphone ea nako le e le 'ngoe kapa tse peli tse potlakileng tsa ho qala ho etsa li-opioids tse potlakileng tsa bohloko ba pelehi bo potlakileng. Ho latela taelo ea hae ho ne ho bile monate haholo ka lipalo tse nepahetseng tsa pilisi. Ho ne ho tloaelehile hore a be le lipilisi tse bohloko tse saletseng khoeli e 'ngoe le e' ngoe. O tlaleha hore o nyenyefatsa ts'ebeliso ea li-analgesics tsa opuliid hantle hobane o ne a sa rate tsela eo ba mo utloisang ka eona. Ka lebaka leo, meriana ea hae e atlehang hangata e ne e sa hloke ho tlatsoa. Lits'oants'o tsa hae tsa lithethefatsi tse sa sebetseng li ne li lula li loketse.

J o tlalehile ho nona ho feta morao kamoo a hopolang. O ile a tšoenyeha ka lebaka la ho ba motenya haholo. Nakong ea tlhahlobo ea bongaka ea bariatric boima ba hae e ne e le 348 lbs. Nakong e fetileng o ne a lekile lijo tse ngata a sa atleha. O ile a tsuba koae 'me a leka ka matla ho tlohela “makhetlo a mangata” empa a sa atlehe. O ile a lumela hore o tšoenyehile ka hore o na le 'mele oa ho fokotsa boima ba' mele ka ho tlohela ho tsuba. Khaitseli ea hae, ntate oa hae le monna oa hae ba tsubang lisakerete kaofela ba ne ba le batenya. Ha a na nalane ea boits'oaro bo qobelloang ntle le ho qeta nako ho feta tekano. J o tlalehile ho nona haholo ha a tšoenyehile kapa a sithabetse mme a ikutloa a le molato ka mor'a moo. O tlaleha hore hangata o ikutloa a khotsofetse ka tsela e tloaelehileng. O ne a na le nalane ea khatello ea maikutlo eo a neng a e tšoaretsoe. O ne a e-na le lenyalo le tsitsitseng, a se na bana ebile a hiretsoe ho ba mooki ea ngolisitsoeng sepetlele sa mofetše sepetlele.

Kaha boima ba hae bo ne bo kenya letsoho haholo ho mathata a hae a mangata a bongaka le a bohloko bo sa foleng, J o ile a hlahlojoa bakeng sa ho buuoa ka bariatric. Kamora ho phethela katleho ea tlhahlobo ea bongaka pele le lenaneo la thuto, J o ile a etsa opereishene e atlehileng ea mpeng mme o ile a ba le thuto e sa amaneng. Ha a ne a latela tleliniking ea rona ea bohloko hoo e ka bang libeke tse tharo kamora ho mo buoa o ne a se a lahlehetsoe ke liponto tse leshome le metso e mene. O ile a tsoela pele ho theola boima ba 'mele likhoeling tse 8 tse tlang mme le ha re ne re lebelletse hore tahlehelo ena ea boima ba' mele e be le phello e ntle taolong ea bohloko, J o lula a tletleba ka bohloko ba lengole le mokokotlo mme a tsitlallela ho sebelisa meriana ea morao-rao e latelang. O ile a letsetsa tliliniki ea rona ka makhetlo a 'maloa a kopa ho khethoa pele ho nako ka lebaka la ho qabanya likhohlano le mosebetsi le boitlamo ba hae ba lelapa. Ho fapana le bongaka ba pelehi, J le eena o ile a lebala ho mo tlisetsa botlolo ea lipilisi nako ea ho ba balla joalo ka tloaelo ea rona.

Likhoeli hamorao ho ile ha phetoa skrineng ea lithethefatsi tsa moroto tse sa sebetseng. Sena se ne se loketse bakeng sa moriana oa hae oa taolo o laoloang, le hoja katleho ea hae e ne e le sieo. Tlhaloso ea hae ea ho se be teng mona ke hore o ne a sa e hloka matsatsi a 'maloa pele a beoa, ka hona maemo a lithethefatsi a tlameha hore ebe a theohile hore a se ke a bonoa. Likhoeli tse 'maloa hamorao, leseli le leng la taolo le sa kopaneng la lithethefatsi le ne le le molemo bakeng sa li-benzodiazepines. Qalong o ile a tsitlella hore ena ke phoso. Leha ho le joalo, qetellong o ile a lumela ho nka clonazepam matsatsi a 'maloa pele ho nako ea ho khethoa bakeng sa matšoenyeho. O boletse hore pilisi ena e ne e tlohe ho lengolo la ngaka la khale haholo leo a neng a hloleha ho le lahla. Sebakeng sa clonazepam. Teko ea netefatso ea GC / MS e ileng ea khutla matsatsi a 'maloa hamorao e ne e le ntle bakeng sa alprazolam metabolites, hammoho le ethyl glucuronide (ETG), letšoao la tlhahlobo ea ts'ebeliso ea joala matsatsing a' maloa a fetileng. Le ha a ne a sa tsamaisane hantle le tekanyo ea ts'ebeliso ea joala, boemo ba hae ba 25,000 bo ne bo se bo sa tsoane le ho feta ka 1000 ng / dl. Kaha ho kenyelletsa meriana le taolo ea joala e ne e le tlolo ea tumellano ea hae ea opioid, J o ile a bitsoa mme a bolelloa hore a kene hanghang.

Qalong J o ile a hana bonnete ba sephetho, leha ho le joalo, ha a tobane le monyetla oa ho tsoa litsing tsa kliniki o ile a lumela ho nka Xanax ka linako tse itseng tseo a li fumaneng ho "motsoalle" mme "o ne a e-ba le seno se kopang" ka linako tse ling bakeng sa matšoenyeho. Kamora puisano e telele ea likotsi tsa ho kopanya li-benzodiazepine le li-opioid, haholo-holo ka ho koala likokoana-hloko tse amanang le boroko le ho hlahloba melao-motheo ea bongaka le eena, J o ile a lumela ho latela ASAP le ngaka ea mafu a kelello bakeng sa tlhahlobo le kalafo e loketseng ea matšoenyeho a hae. O ile a re tiisetsa hore sena se ke ke sa etsahala hape. O bolokile tumellano ea hae ea mafu a kelello bekeng e latelang mme ngaka ea hae ea mafu a kelello e ile ea eketsa duloxitine ho isa ho 90 mg / ka letsatsi, pregabalin ea hae ea 100 mg, mme a hlophisa hore a fuoe tlhabollo le ho qala kalafo ea boits'oaro ea kelello. Hamorao bekeng eona eo tleliniki ea rona e ile ea fumana molaetsa o tsoang ho J o bolela hore meriana ea hae e utsuoa mantsiboeeng a fetileng mme a kopa lengolo la bongaka. O boetse a re hopotsa hore sena ha se so ka se etsahala nakong e fetileng. O ile a bolelloa hore a tlise tlaleho ea mapolesa. Ha a fihla, o ile a kopa lengolo la ngaka mme a halefa ha a bolelloa hore o hloka ho saena bakeng sa tumellano e felletseng le puisano ea liketsahalo le ngaka ea hae. Matšoao a hae a bohlokoa a ne a le bohlokoa bakeng sa sekhahla se phahameng sa pelo le khatello ea mali e phahameng. Baithuti ba hae ba ne ba hlapollotsoe 'me a bonahala a ferekane. Ha a bolelloa hore o hloka ho fana ka moroto bakeng sa skrineng sa lithethefatsi tse pheta-phetoang, J o ile a halefa haholo, mme a re o tšoeroe ke feberu mme o bile le lets'ollo le khatello ea maikutlo ea GI mme mohlomong o bile le metsi haholo ho fana ka sampole ea moroto. Re ile ra mo hlalosetsa hore ena ke ntho ea bohlokoa, 'me a re a lule ka kamoreng ea ho leta' me a noe metsi ho fihlela a khona ho etsa joalo. Motsoako oo a o fumaneng o ile oa tsebahala hore o hlapoloha haholo, ha o bate mocheso oa kamore ebile o le mabe bakeng sa lithethefatsi tsohle. Ha a tobana le liphetho tsena, o ile a hlonama 'me qetellong a lumela hore meriana ea hae ha e so utsuoe empa hore o hlile o ba sebelisitse hampe le hore o felile kapele. Ntle le moo, J o ile a ipolela hore o ea tleliniking e 'ngoe ea bohloko mme o fumana meriana e meng ea opioid. O kopa hore re fetise tlhokomelo ea hae moo. Ha re ba bolella hore re hloka ho ba letsetsa ho tla bua ka liketsahalo tsena, o ile a tlola mme a lumela hore o ikutloa hore o na le bothata le joala le opioids, mme o ne a noele haholo likhoeling tse tšeletseng tse fetileng mme a e patela lelapa la hae. O boletse hore o lekile ho tlohela ho tahoa kamora joala ba hae bo bobebe ba moroto empa a ba le "jitters" le nausea. O boetse a lumela hore o ne a ntse a nka Xanax makhetlo a 'maloa ka letsatsi likhoeling tse' maloa tse fetileng. O ne a boetse a ja lijo tse ngata kamehla. Qetellong, o ile a lumela hore bohloko ba hae bo hlile bo ntlafetse hammoho le ho theola boima ba 'mele, leha ho le joalo o ile a kopanya matšoao a hae hobane meriana ea bohloko e ne e bonahala e mo phahamisa maikutlo mme o ne a ikutloa hore a ka se khone kantle ho bona. O ile a lumela hore o ikutloa a sa thaba, hore bophelo ba hae bo ne bo se taolong mme o ne a le le maikutlo a letsoalo le potileng boitšoaro ba hae bo thetsang mme haufinyane o ne a bile le maikutlo a ho ipolaea. J o ne a batla thuso mme a lumela ho amoheloa hang hang setsing sa rona sa tlhekefetso ea lithethefatsi. Ha a le detox, o ile a boela a lumela hore o sa tsoa qala ho khelosa dilaudid ha a le mosebetsing le hore e mong oa basebetsi-mmoho le eena o sa tsoa tla ho eena a botsa hore na tsohle li hantle. O ne a utloa eka ke taba ea nakoana pele a ka fumanoa.

Ha a ntse a le kalafong, J o ile a beoa ho buprenorphine bakeng sa bohloko, a amohela ho lemalla bokhoba, a qala ho ea libokeng tsa AA le NA, mme a fumana motšehetsi ea mo tataisang mehatong e 12 ea lino tse tahang. Matšoenyeho a hae le khatello ea maikutlo li se li ntlafaletse mme o ntse a tsoela pele ho nka karolo ho tsa kalafo ea kelello / boits'oaro bo botle. Ho fokotsa boima ba 'mele ea hae ho bile boima butle empa o tsitsitse, mme ts'ebetso ea hae ho latela tleliniking ea rona ea bohloko e bile 100%. O bile le seabo khafetsa ka beke ho kalafo ea aqua. Ka nako ena J o ntse a tsoela pele ho nka luprenorphine e sa lekanyetsoang ka tekanyetso ea limiligrama tse 'ne ka lihora tse ling le tse ling tse robeli. Boima ba hae hona joale ke li-lbs tse 214 mme o saenetse konteraka ea lilemo tse hlano le lenaneo la ho hlokomela baoki ba holofetseng mme o na le tšepo ea ho lumelloa ho khutlela mosebetsing.

Case 4

Monna ea lilemo li mashome a mahlano a metso e mehlano ea neng a le boima ba limmone tse mashome a mane a metso e mehlano pele a buuoa kapele ka mpeng. O ne a e-na le BMI ea 423. O entse hantle kamora ho buuoa mme joale o boima ba li-lbs tse 63. O fetisitse temallo ea hae ea lijo hore a ikoetlise. O matha metjeko mme o ikoetlisa ka makhetlo a mahlano ka tumelo. O se a mathile li-marathone tse halofo mme o rera ho matha lebelo le felletseng (limilithara tse 180) ka likhoeli tse 'maloa. Ona ke mohlala oa temallo e ntle ea phetisetso.

Case 5

Mosali ea lilemo li 44 ea neng a e-na le leqeba la ka mpeng bakeng sa BMI ea likhoeli tse XNUMX tse fetileng. Post ha a ntse a sebetsa o ne a sa tsamaisane le livithamini tsa hae mme o se a qalile ho tsuba le ho noa kofi haholo. Leha a fuoa tlhabollo ea khauta ka ho tsuba, o ntse a tsuba. O hlalositsoe ka kotsi e eketsehang ea ulcer ea bohloko ba ka mpeng ho bakuli ba tsubang.

Ka lebaka la liketsahalo tsena tse ncha ho lumellanoa hangata ke lingaka tsa bariatric ho pholletsa le Amerika hore litlhahlobo tse phethahetseng tsa 'mele le tsa kelello tse amanang le ts'ebetso e kopantsoeng le tlhokomelo ea bongaka e tsoelang pele le tlhabollo ea ts'ehetso kamora ts'ebetso e bohlokoa bakeng sa ho netefatsa sephetho se setle ho bakuli ba etsang opereishene ea bariatric. Bakuli ba tlang kamoso ba ka ba le nalane ea fetileng kapa ea hona joale ea mathata a fapaneng a bophelo bo botle ba kelello, ho kenyeletsa ho itlopa joala kapa ho lemalla koae, joala, lithethefatsi kapa lintho tse ling tse seng molaong; ts'ebeliso e mpe ea lithethefatsi e sebelisoang hangata e nkuoa e le lebaka la ho khetholla mokuli ho buoa. Leha ho le joalo, mananeo a tlhahlobo ea kalafo ea pele ho ts'ebetso e joalo ka tlhahlobo ea liphatsa tsa lefutso a ka ba hole haholo ho thusa ho tseba batho ba anngoeng ke mathata a joalo [23] 'me u ba lumelle hore ba fuoe kalafo e le hore ba tsebe ho hlola temallo ebe ba hlahlojoa bakeng sa bongaka ba bariatric nakong e tlang.

Tloaelo e tloaelehileng ea dopaminergic ea lijo le litakatso tsa litakatso tsa lithethefatsi

Ehlile, ho ja lijo tse matlafatsang ho feta tekano ho batho ba batenya ho tšoana le ho lahleheloa ke taolo le boitšoaro bo qobelloang ba ho sebelisa lithethefatsi bo shebiloeng lithutong tse lemaletseng lithethefatsi. Mokhoa oa boitšoaro bona ha o utloisisehe hantle. Leha ho le joalo, lithuto tsa morao tjena tse entsoeng ke Wang et al. [24] ka positron emission tomography (PET) lithutong tse lemaletseng lithethefatsi tse ngotsoeng tse fokotsang litheko ho li-striatal dopamine (DA) D2 receptors. Lithutong tse batenya tsa mafu a kelello, bafuputsi ba tšoanang [25] a fumana phokotso ho li-receptor tsa DA D2 tse ts'oanang le tse ling tsa lithethefatsi tse lemaletseng lithethefatsi. Ntle le moo, maemo a receptor a DA D2 a fumanoe a e-na le kamano e fapaneng le index ea boima ba 'mele ea lithuto tse batloang. Wang et al [25] e hatisang litekanyetso tse fokotsehileng tsa li-receptor tsa DA D2 tse rerileng esale pele lithuto tsa ho batla litlatsetso; litabeng tsa lithuto tse lemalloang ke lithethefatsi, lithethefatsi le litabeng tsa litso tsa botona, lijo e le mokhoa oa ho buseletsa ka nakoana bakeng sa kutlo e fokotsehileng ea litheko tsa meputso ea DA D2 e ​​laolitsoeng. Ho utloisisa mekgwa e kenyelletsang ho ja lijo ho tla u thusa ho fana ka litlhahiso mabapi le mekhoa ea ho phekola botena. Kutloisiso ena e entsoe lipatlisiso ke Stice le metsoalle ho senola hore bakuli ba DRD2 A1 allele ba bonts'a karabelo e sa nepahalang ea ho potoloha lijong tsa manonyeletso le hore bajari ba lipopae ba D2 le mefuta ea D4 ba nang le karabelo e sa hlakang ba fumana boima ka selemo se le seng. tšalo-morao [26-28].

Ho feta moo, ho fokotseha ha methapo ea kutlo ea dopaminergic ho etsa hore moputso o fokotsehe le boits'oaro bo bobe ba ho ja ka botenya. Le ha opereishene ea Bariatric ke eona kalafo e sebetsang ka ho fetisisa ea botena le ho fokotsa tlala kapele le ho ntlafatsa satiety ka mekhoa e sa tsejoeng e tsebahala ka ts'ebetso ea dopaminergic kamora ts'ebetso ena ea ho buuoa. Volkow et al [29] hypothesised hore dopaminergic neurotransication e tla ameha kamora ho buuoa ka Roux-en-Y-Gastric Bypass (RYGB) le Vertical Sleeve Gastrectomy (VSG) le hore liphetoho tsena li ka susumetsa boits'oaro ba ho ja le ho kenya letsoho liphellong tse ntle tse tsoang ho ts'ebetso ea bongaka ea bariatric. Thutong ea bona, boima ba 'mele bo ile ba fokotseha kamoo ho neng ho lebelletsoe ka mor'a ho buuoa. Ho fumaneha ha li-receptor tsa DA D2 ho fokotsehile kamora ho buuoa. Ho fokotseha ha libaka (ho bolela +/− SEM) ho ne ho le joalo ka 10% / 3%, putamen 9 +/− 4%, ventral striatum 8 +/− 4%, hypothalamus 9 +/− 3%, substantia nigra 10 +/− 2% , medial thalamus 8 +/− 2%, le amygdala 9 +/− 3%. Tsena li ne li tsamaea le ho fokotseha ho hoholo ha plasma insulin (62%) le leptin (41%).

Volkow le al. [29] e supa ho fokotseha ho fumaneha ha li-receptor tsa DA D2 kamora RYGB le VSG haholo ho bonts'a ho eketseha ha maemo a dopamine a extracellular. Matlafatso ea dopaminergic neurotransication e ka kenya letsoho ho ntlafatseng boitsoaro ba ho ja (mohlala, ho fokotsa tlala le ho ntlafala ha satiety) kamora mekhoa ena ea bariatric. Leha ho le joalo, e kanna ea bonts'a ho fokotseha ha kholo ea kelello ea D2 / D3 receptor ka nako e telele e tla matlafatsa boikarabello ba ho lemalla le ho lebisa ho feteng ts'ebeliso ea lithethefatsi tsa ts'ebeliso ea lithethefatsi kapa ts'ebetso ea mamello. Liphumano tsena li ka ba le bohlokoa ba 'nete ba ho hlalosa karolo e' ngoe ea kotsi ea ho batla lithethefatsi kamora ho buuoa ka bariatric. Leha ho le joalo, ke tšibollo ea rona mona hore 'muelli oa' nete a ka phela maemong ao re a entseng re bitsitse RDS le liphatlalatso tsa lefutso [30].

Neurogenetics ea RDS e le motsoako oa lijo le litakatso tsa lithethefatsi

Mohopolo o mong o mocha oa botenya ba lefu la seoa ke bokhoba ba lijo, bo amanang le mathata a tšebeliso ea lithethefatsi le lijo. Bopaki bo hlahang bo bontšitse hore ho na le litsela tse ngata tsa neural, li-hormone le liphatsa tsa lefutso le li-antecedents tse arolelanoang. Lipatlisiso tse sebetsang tsa neuroimaging li bontšitse hore ho matlafatsa lijo ho na le litšobotsi tse ts'oanang le tsa lithethefatsi tsa tlhekefetso. Ho feta moo, liphetoho tse ngata tsa boko tse tlalehiloeng bakeng sa ho ja le ho nona haholo li boetse li bonahala ka mekhoa e fapaneng ea bokhoba. Tumellano ea lingoliloeng e fana ka maikutlo a hore ho nona haholo le botena ho ka ba le ts'ebetso e kang ho lemalla lithethefatsi mabapi le tšusumetso le takatso, takatso, takatso le ho rata. Lintho tsena tsa boits'oaro li hlaha kamora ho ba le litlolo tsa pele le tse pheta-phetoang ho susumetsa. Liu et al [31] o fihletse qeto ea hore tlhoko e fumanoeng ea lijo le bofokoli bo lekanyelitsoeng ba letšoao la satiety li tla baka tsitsipano pakeng tsa drive le litsi tsa tlala / meputso bokong le molao oa tsona.

Warren le Khauta [32] o bontšitse kamano e teng lipakeng tsa botenya le ts'ebeliso e mpe ea lithethefatsi ha a araba pampiri ke Kalarchian et al. [33] ea fumaneng hore karolo ea 66% ea bankakarolo e ne e e-na le nalane ea bophelo ba axis I e le 'ngoe, mme 38% e ile ea kopana le litekanyetso tsa tlhahlobo ka nako ea tlhahlobo ea ts'ebetso ea bongaka ea bariatric. Ntle le moo, 29% e kopane le litekanyetso tsa koluoa ​​e le 'ngoe kapa tse' maloa tsa axis II. Axis I psychopathology, empa eseng axis II, e ne e amana hantle le BMI, mme li-axis I ka bobeli le axis II psychopathology li ne li amahanngoa le lintlha tse tlase lithutong tsa Medical Outcome 36-element Short-form Health Survey. E ile ea phethoa ka mathata a kelello le a nakong e fetileng a DSM-IV (ho kenyeletsa le boits'oaro bo bongata ba taolo) e atile har'a lingaka tsa lingaka tsa bongaka mme e amana le botena bo boholo le boemo bo tlase ba ts'ebetso ea bophelo bo botle, e totobatsang tlhokeho ea ho utloisisa menyetla e ka bang teng bakeng sa boitokisetso ba ho buuoa le sephetho.

Ehlile, mekhoa ea ho ja e ts'oana le ea lits'oaetso tse ling kaha bobeli bo ama maemo a dopamine tsamaisong ea dopaminergic e phahameng haholo [34]. Ho thehiloe ka nepo hore ho na le keketseho e atileng ea batho ba batenya haholo ba ts'oereng DRD2 Taq A1 allele [35-39] mme allele ena e hokahane le maemo a tlase a li-receptor tsa D2 ho batho ba batenya haholo [40-43].

Bakeng sa ho etsa liphuputso tse atileng tsa taq I A1 allele ea dopamine receptor gene (DRD2) bothateng bo feteletseng le ntle le ts'ebeliso ea ts'ebeliso ea lithethefatsi tsa comorbid, Blum et al [44] e batlisitse kakaretso ea bakuli ba 40, ba tsoang tleliniking ea bakuli ba tsoang kantle ho neuropychiatric e Princeton, New Jersey, ka ho ngola genotyping bakeng sa boteng kapa ho ba sieo ha allele ea Taq I DRD2 A1. Ho ata ha li-alleles tsa Taq I A1D2 dopamine receptor (DRD2) ho ile ha etsoa qeto ho basali ba batona le ba batona ba 40 ba Caucasus. Mohlala ona o nang le BMI e bolelang ea 32.35 +/- 1.02, al1 allele ea mofuta oa DRD2 e ne e le teng ho 52.5% ea lithuto tsena tse nonneng. Ntle le moo, ba fumane hore lihloohong tse 23 tse nang le botenya tse nang le bothata ba ts'ebeliso ea lithethefatsi tse nang le comorbid, ho ata ha DRD2 A1 ho eketsehile haholo ha ho bapisoa le lithuto tsa batho ba batenya tse 17 ntle le bothata ba ts'ebeliso ea lithethefatsi. Phallo ea DRD2 A1 e ne e le teng ho 73.9% ea lithuto tse nonneng tse nang le bothata ba ts'ebeliso ea lithethefatsi ha li bapisoa le 23.5% lithutong tse ngata ntle le bothata ba ts'ebeliso ea lithethefatsi. Ho feta moo, ha re lekola ts'ebeliso e mpe ea ts'ebeliso ea lithethefatsi (joala, ts'ehetso ea cocaine, jj.) moo 2% (1/66.67) ea li-proband tse seng thata haholo li nang le allele ea A8 ha e bapisoa le 12% (1/82) ea linyeoe tse mpe ka ho fetisisa. Litlhahlobo tsa linear li bonts'a hore ts'ebeliso e ntseng e eketseha ea lithethefatsi e ne e le hantle ebile e amana haholo le tlhophiso ea A9 allelic (p <11). Lintlha tsena tsa pele li fana ka maikutlo a hore boteng ba mokokotlo oa DRD1 A0.00001 bo tiisa likotsi tse eketsehileng eseng feela bakeng sa botenya, empa le bakeng sa boits'oaro bo bong bo amanang le bona bo ts'ehetsang ho ts'ehetsa ho tšoana ho teng lipakeng tsa ho lemalla lijo le lithethefatsi. Ka hona, batho bana ba sebelisa lijo ho phahamisa maemo a bona a dopamine qalong ka matlafatso a matle empa ea bobeli ka lebaka la karabelo e putsoa ea potoloho ea lijo tse hlabosang joalo ka ha ho supiloe ke sehlopha sa Stices [26-28] e bakang letšoao le fokolang la satiety le lebisang ho boima ba mmele. Ehlile ho bontšitsoe hore ts'ebetso ea dopamine bokong e ka tsamaisana le mokhoa o sa tloaelehang oa ho ja, ho itlopa lijo le mathata a mang a ho ja ho kenyelletsa bulimia [45-47]. Mabapi le liphatsa tsa lefutso le mathata a ho ja ho bile le lithuto tse ngata tse hokahanyang mefuta e fapaneng ea mathata a ho ja le li-polymorphisms tsa gene: serotonergic [48-51], li-receptor le li-peptide tsa opiate [52-57] le GABA [58-60].

Hoa tsebahala hore mefuta e mengata e kenella mekhoeng e rarahaneng ea boits'oaro e kenyeletsa boits'oaro bo lemalloang Li et al. [61] ba etsa tlhahlobo ea meta ea mefuta e 396 e neng e tšehelitsoe ke lintho tse peli kapa ho feta tse ikemetseng tsa bopaki ho tsebahatsa litselana tse 18 tsa limolek'hule tse ileng tsa matlafatsoa ka palo, tse koahelang liketsahalo tse hlahelletseng tse bontšang liketsahalo le litlamorao tse theohelang. Litsela tse hlano tsa limolek'hule tse ntlafalitsoeng haholo bakeng sa mefuta eohle e fapaneng ea lithethefatsi tse lemallo li bonts'oa e le litsela tse tloaelehileng tse ka tlatselletsang liketso tse khotsofatsang le tse tlatsetsang, ho kenyelletsa tse ncha tse ncha. 'Mapeng oa bona oa liphatsa tsa lefutso ba fumane hore litsela tsohle li lebisa ho li-neurotransmitters tse peli tse tloaelehileng tse bitsoang glutamate le dopamine.

Kahoo neurotransmitter ea bokhoba ba tahi, DA, e na le ts'ebetso e ikhethileng ea taolo ea lijo mme e tiisa litlamorao tsa lijo [62]. Joalokaha Stice et al. [63] le ba bang [64] ba khothalelitse dopamine ho hlokahala ho qala ts'ebetso ea lijo. E sebetsa sebakeng sa pele, "ventral medial hypothalamus" le "nucleus" e fokotsang lijo ho theola takatso ea lijo le ho thibela hyperphagia, eo ka mor'a moo e susumetsoang ke leptin, insulin le lihormone tse ling [64]. Blum le Khauta [65] li hlahisitse pherekano mosebetsing oa DA e ka etsa hore batho ba bang ba se ke ba ba le boitšoaro bo bobe le botenya.

Mefuta ea liphoofolo tse lemalloang ke lijo

Ho khahlisang, mehlala ea liphoofolo e bontšitse hore tšitiso ea ts'oaetso ea lijo ho bana e hlahisitsoe ke ho fepa bo-'mè lijo tse se nang phepo tse nang le mafura, tsoekere le linoko tse letsoai nakong ea bokhachane le pelehi.67]. Bana ba likhoto ba bontšitse ho eketsa boima ba 'mele le BMI ha e bapisoa le lits'ebetso, ha bo-mme ba bona ba itlopa lijo tse nang le phepo e ngata le tse ngata tsa junk [67]. Maikutlo ana a ka ba le bohlokoa ho bo-mme ba baimana ba latelang bongaka ba Bariatric mabapi le lijo hore ba be le bana ba phetseng hantle ba nang le takatso ea lijo le boima. Le ha ho ja lijo tse nang le phepo e nepahetseng nakong ea kemolo ho khothalletsoa, ​​bothata bo ka ba thata le ho feta. Motho o boetse o tlameha ho nahana ka phello e ka bang teng ea genodics ea hypodopaminergic ho 'm'a eaimeng e ka hanang ho khothaletsoa ha lijo tse matlafatsang ka nako e telele. Avena et al. [68] e fumane bopaki bo hlakileng ba hore tsoekere e na le litšobotsi tse tlatsetsang ho tloha ha e lokolla li-opioid ka bobeli le dopamine, e leng tšobotsi ea bokhoba ba tahi. Ho feta moo, bangoli ba tšoanang [68] e khethiloe tsoekere e le ntho e lemalloang hobane e latela tsela e tloaelehileng ea ho lemalla eo ho latela Blumenthal le Khauta [69] le Liu et al [31] e na le ho loma, ho nqeta, ho lakatsa le ho etsa lintho tse ling. Ha e le hantle, maikutlo a tšenyo ea bongata a ile a bonoa litotong tse bonts'ang ho tloha ho tsoekere ho ea ho lithethefatsi [70]. Mosebetsi oa morao-rao o makatsang ke Cantin et al. [71] e fumane hore cocaine e tlase lenaneng la boleng ba likhoto tse ngata, haufi le botebo bo tlase ba metsi a monate. Ntle le moo, tlhahlobo e lekolotsoeng ea liteko tsohle lilemong tse 5 tse fetileng e bontšitse hore ho sa tsotelehe tšebeliso ea koae e neng e le boima hakae nakong e fetileng, e tlohela habonolo tšebeliso ea koae molemong oa mofuta oa nondrug (Saccharin). Ke ba fokolang feela, ba ka tlase ho 15% ka tekanyo e boima ka ho fetisisa ea ts'ebeliso ea koae e fetileng, ba ileng ba tsoela pele ho nka koae, leha ba lapile mme ba fana ka tsoekere ea tlhaho e ka felisang tlhoko ea bona ea likhalori. Habohlokoa ho hoholo le Le Moal [72] fana ka maikutlo a hore ho hlokahala hore maikutlo le mamello ea sefapano li qale ho qaleha mofuta ofe kapa ofe oa bokhoba 'me ka lebaka leo tsoekere e tšoanela mohlala ona.

Mabapi le ho tlohela, ho ho khahlisang hore ho tlosoa tsoekere ho etsa hore ho be le ho leka-lekana ho li-acetylcholine le dopamine e ts'oanang le ho tlohela ho tsibollo. Ka ho khetheha, Avena et al [73] e fumane hore likhoto tse tlisoang ke ho itlopa lijo tse tsoekere ka tšebeliso ea maqhubu a limela li senotse keketseho e ts'oanang ea acetylcholine ea extracellular le ho theoha ha tlhahiso ea dopamine mokokotlong oa li-nucleus accumbens. Se fumanoeng se fana ka maikutlo a hore ho ja ka mokhoa o ikhethileng ho sucrose le chow ho lateloang ke ho itima lijo ho theha boemo bo kenyelletsang matšoenyeho le algelopoline e fetotsoeng. Sena se tšoana le litlamorao tsa naloxone, ho fana ka maikutlo a ho khaotsa ho tšoana le opiate. Sena e kanna ea ba sesosa sa mathata a itseng a ho ja.

Ha ho ntse ho na le ho tšoana lipakeng tsa lijo le lithethefatsi mabapi le bokhoba ba ho lemalla ba bang ba pheha khang ea bona ea hore ke mohlala oa botenya motheong oa hore lijo ka se e se lithethefatsi tse hlaselang kelello [74]. Ha ho buuoa joalo, Seminar ea Univesithi ea Columbia mabapi le Appetitive Behaeve, lefu lena la botenya le ile la hlahisa lisosa tse fapaneng, eo e 'ngoe e leng mohopolo oa "tšebeliso ea lijo". Taba ena e phehisanoe ka matla mokhoeng oa phatlalatso [75] le sechabeng sa mahlale [76-77].

Mekhoa e bukeng ea Diagnostic & Statistical Manual of Mental Disorders, Khatiso ea bone (DSM-IV) e mabapi le ts'ebeliso e mpe ea lithethefatsi le eona e sebelisitsoe ho lemalla lijo bathong ke Gearhardt et al. [78]. Mabapi le tsoekere e nkoang e le ntho e bolokang kelello ho na le litlaleho tsa tliliniki tseo ho tsona batho ba lemaletseng lijo ba itšebelisang ba sebelisa lijo ho itlhalosa; hangata ba ja e le ho baleha boemo bo seng botle ba maikutlo [79]. Bangoli ba boela ba tiisa hore ho nona ho feta tekano ho ka hlalosoa e le tšibollo ea lijo tse ntlafalitsoeng tse lumellanang le litekanyetso tsa DSM-IV tsa mathata a tšebeliso ea lithethefatsi. Litlaleho tse hlahisoang ke bokhoba ba lijo tse iponahalitseng li bontša boitšoaro bo lumellanang le litekanyetso tse 7 tsa DSM-IV tsa mathata a tšebeliso ea lithethefatsi [79]. Khopolo ena e tloaelehileng e netefalitsoe ke lithuto tse bonts'ang hore litakatso tsa lijo tse boima bo tloaelehileng mme bakuli ba batenya haholo ba kenya tšebetsong likarolo tsa boko tse ts'oanang le tse bontšitsoeng ho batleng lithethefatsi [25,80].

Tekong ea morao-rao ke Nicole Avena [81] moo a ileng a akaretsa bopaki ba "bokhoba ba lijo" a sebelisa mefuta ea liphoofolo ea ho ja ka mokhoa o hlakileng o hlalositseng hantle ho itlopa lijo, ho itlosa le ho lakatsa ka ho hlahisa bopaki ka ho sebelisa mohlala oa phoofolo ea ho itlama ka sucrose kapa ho loma glucose.

Avena et al [82] etsa tlhahlobo-leseling a sebelisa mofuta oa mofuta oa polelo ea puo le PANTHER ka mefuta e 152 e ikhethang e bakileng likabelo tse 193 tse arotsoeng ka mekhahlelo e 20. Hoa hlokomeleha hore sehlopha sa ho ja lijo tse hlapantsoeng ka bongata ha se bapisoa le sehlopha sa lipapatso sa libes se ile sa fella ka hore ho be le lihlopha tse fapaneng tsa mofuta oa polelo. Liphumano tsena li shebahala li fetoha ha motho a nahana ka li-neurotransmitter tse kenyelletsang ho litefiso tsa moputso oa boko (mohlala, serotonin; endorphins; GABA; Dopamine; Cannabinoids; Acetylcholine) ka ho khetheha moputso oa boko moputso [83] le RDS [30]. Ho khahlisang Avena et al o fumane phapang e kholo lipakeng tsa ho itlopa joala le ad libitum sucrose lihlopheng tse 'maloa tsa methapo ea methapo ka mohlala: Cholinergic Receptor-CREB signaling (P <0.001677); Letšoao la Leptin Receptor -ELK-SRF (P <0.001691); Pontšo ea Dopamine D2 Receptor -AP-1 / CREB / ELK-SRF (P <0.003756); Pontšo ea Serotonin-Fos (P <0.00673); Pontšo ea Cannabinoid -AP1 / EGR (p <0.015588) le Opioid receptor -CREB / ELK-SRF / Stat3 signaling (P <0.01823). Liphuputso tsena tsa phapang e kholo liphatseng tsa lefutso tsa methapo ea kutlo sehlopheng sa ho itlopa joala ha li bapisoa le sehlopha sa ad libitum li fana ka bopaki ba bohlokoa ba ho fana ka maikutlo a ho nka karolo ha potoloho ea moputso oa boko ka ho itlopa joala ka bonngoe. Liphetho tsena ho liphoofolo li kanna tsa amana le ho itlopa joala bathong e leng karoloana ea RDS.

Khaello ea Moputso le Tlatsetso ea Lijo: Neurochemical tloaelehileng ho lithethefatsi tsa tlhekefetso

Ka 1996 nna le metsoalle ea ka re ile ra theha polelo RDS e ntseng e hlaha e le tlhaloso e amohelehang ea kamano e kopaneng ea boitšoaro bo qholotsang - bo qobelloang le bo lematsang [30]. Ka nako eo re ne re sebelisa theorem ea Bayes ho bolela bokamoso ba ntho e tlang le boits'oaro bo khelohileng. Sistamin ea dopaminergic, haholo-holo dopamine D2 receptor, e bile le tšusumetso e matla mokhoeng oa meputso mochophorong o mong oa litho tsa boko. Ho se sebetse hantle ha D2 dopamine receptors ho lebisa ho ntho e tlisoang ke joala (joala, lithethefatsi, koae le lijo). Lilemo tse mashome tsa boithuto li bonts'a hore liphatsa tsa lefutso li bapala karolo ea bohlokoa tlokotsing ea ts'ebetso e matla ea ho batla lithethefatsi. Re khothalelitse hore mefuta ea D2 dopamine receptor gene (DRD2 A1 allele) e bohlokoa liphatlalatsong tsa liphatsa tsa lefutso ho bolela esale pele mafu a tlatsetsang. Thutong eo, boleng ba ponelopele bakeng sa boits'oaro ba RDS bo tlang lithutong tse nkileng DRD2 Taq A1 allele e ne e le 74% [84]. Kamora tlaleho ena lithuto tse ngata li tšehelitse mohopolo ona o hokahanyang takatso ea lijo le boits'oaro ba litakatso tsa lithethefatsi o sebelisa lisebelisoa tsa neuroimaging [85-86].

Ho bonahala hore ha liphatsa tsa lefutso tse ngata li kentse letsoho lits'ebetsong tsa RDS dopamine D2 receptor e bapala karolo e kholo [87]. Johnson le Kenney ba hlokometse boitšoaro bo qobelloang joalo ka ho ja lijo tse batenya empa eseng litheko, tse lekantsoeng joalo ka tšebeliso e ntle ea lijo tse neng li sa khone ho sitisoa ke ts'usumetso e hlohlelletsang. Li-receptor tsa Striatal dopamine D2 li ne li kengoe ka likhoto tse ngata haholo, 'me ho tlalehiloe ho batho ba batenya haholo.25] le batho ba lemaletseng lithethefatsi. Ho feta moo, li-receptor tse amohelang matla a lentivirus tse potlakisang lebelo li ile tsa potlakisa nts'etsopele ea bofokoli ba meputso e tlisoang ke bokhoba le ho qaleha ha lijo tse qobelloang tse batlang likhoto tse nang le phihlello ea lijo tsa mafura a phahameng. Lintlha tsena li bonts'a hore ts'ebeliso e fetelletseng ea lijo tse fumanehang habonolo e baka likarabo tse joalo tsa "neuroadaptive" tse tsamaellanang le liteishene tsa meputso ea kelello 'me e khanna nts'etsopele ea lijo tse qobelloang. Bangoli ba fana ka maikutlo a hore mekhoa e tloaelehileng ea hedonic ka hona e ka eketsa botenya le bokhoba ba lithethefatsi. Hoa hlokomeleha hore ba bang ba ile ba fumana ho tepella ho hoholo ha BDNF ka har'a litoeba tse tsoang ho hemocherial hypothalamus (VMH) ka lebaka la boitšoaro bo feteletseng le botenya. Ka ho khetheha Cordeira et al. [88] e fumane hore polelo ea BDNF le TrkB mRNA sebakeng se senyane sa mofuta oa litoeba tse hlaha li susumetsoa ke tšebeliso ea lijo tse matlafatsang tse nang le mafura a mangata. Ntle le moo, lirekoto tsa amperometric lipapaling tsa boko tsa litoeba tse feletsoeng ke BDNF e sa bonoeng li haotse liphoso tse hlahisitsoeng ka ntle ho tlhahiso ea dopamine ka har'a khetla (NAc) khetla le dorsal striatum empa secretion e tloaelehileng mokokotlong oa NAc. Ho feta moo Lobo et al [89] haufinyane li bonts'itse hore ts'ebetso ea li-neuron tsa D2 +, tse etsisang tahlehelo ea TrkB, e hatella moputso oa koae, ka litlamorao tse fapaneng tse hlahisoang ke ts'ebetso ea li-neuron tsa D1 +. Liphetho tsena li fana ka leseli mabapi le taolo ea limolek'hule tsa tšebetso ea methapo ea D1 + le D2 + hammoho le karolo ea potoloho ea mefuta ena ea lisele ho moputso oa koae.

Receptor ea D2 dopamine e amahantsoe le thabo, 'me DRD (2) A1 allele e se e bitsoa mofuta oa moputso [90]. Bopaki bo fana ka maikutlo a hore ho na le tšebelisano-'mōtoana e kenyelletsang khaello ea dopamine receptor, tekanyo ea tšebeliso e mpe ea joala, le maikutlo a fokotsang kutloisiso. Tšebelisano ena e itšetleha haholo ka litšobotsi tsa lefutso tsa motho eo, ka hore merabe e meng e na le tloaelo e kholo ea bokhoba ba tahi ho feta e meng. DRD (2) e bile e 'ngoe ea lipatlisiso tse atileng ho feta lithutong tsa neuropsychiatric ka kakaretso, le ho joala le lithethefatsi tse ling ka ho khetheha. Mofuta oa dopamine D2, mme haholo allele TaqI A1 allele e kanna ea ameha ho matšoao a bosoasoi ba ho hlonepha botho, ho batla ho hongata haholo, botenya, ho becha le litšobotsi tse amanang le tsona [91]. Sisteme ea mesocorticolimbic dopaminergic pathway e bapala karolo ea bohlokoahali ho kenyang matlafatso ea litlhare tse sebelisoang tlhekefetso, hape e kanna ea ba mokhelo o tloaelehileng bakeng sa lits'ebeliso tse joalo ka bokhoba ba tahi [92].

Ha mesocorticolimbic dopamine moputso dysfunctions (mohlomong e bakoa ke mefuta e meng ea liphatsa tsa lefutso), sephetho ke RDS le boits'oaro bo latelang ba ho batla lithethefatsi. RDS e bua ka ho khaoha ha sekhahla sa moputso, le litlamorao tse tlisoang ke boitšoaro, ka lebaka la tšusumetso ea liphatsa tsa lefutso le tikoloho [30]. Tai le lithethefatsi tse ling tsa tlhekefetso, hammoho le tse ling tse matlafatsang, li baka ts'ebetso le tokollo ea neuronal ea dopamine ea boko, e ka fokotsang maikutlo a fosahetseng mme ea khotsofatsa litakatso tse sa tloaelehang. Khaello kapa ho ba sieo ha li-receptor tsa D2 joale ho beha motho ka mong kotsing e kholo bakeng sa boits'oaro bo bongata ba ho lemalla, bo sa qobellohe le bo qobelloang. Le ha li-neurotransmitters tse ling (mohlala, glutamate, gamma-aminobutyric acid (GABA), le serotonin) li ka ba tsa bohlokoa ho khetholla litlamorao tse matlafatsang le tse tsosang tsa ethanol, dopamine e kanna ea qalella ho qala lithethefatsi le takatso ea lijo le ho khutlisetsa tšebeliso ea lithethefatsi nakong ea ts'ebeliso ea nako e telele ea nakoana [93].

Ho hlahlojoa ha mekhoa e fapaneng ea kalafo bakeng sa boholo ho senola litlamorao tse mpe mabapi le thibelo ea ho khutla le tlala ea lithethefatsi e tsoelang pele. Mekhoa ea phekolo ea lithethefatsi bakeng sa tšebeliso ea lithethefatsi ea lithethefatsi e bile le katleho e fokolang hobane li-activator tsena tse matla li tsepamisitse tlhokomelo ho lokiseng kapa ho kena-kenana le euphoria ea lithethefatsi ho fapana le ho khalemela kapa ho buseletsa bofokoli ba tsamaiso ea dopamine ea pre-morbid. Blum le Khauta [66] e khothalelitse phetoho ea paradigm lithutong tsa bolulo, tseo e seng tsa bolulo le kamora tlhokomelo tse kenyelletsang kenyelletso ea tlhahlobo ea liphatsa tsa lefutso ho khetholla likotsi tsa kotsi tse kopantsoeng le ts'usumetso ea D2 receptor e sebelisang neuroadatogen amino acid precursor enkephlinase -catecholamine -methyltransferase (COMT) thibelo ea thibelo. Tlhahiso e joalo ea tlhaho empa e le pheko e ka etsang hore ho lokolloe ha DA e ka baka ho kenngoa ha D2 e ​​laetsoeng ke MRNA le keketseho ea li-receptor tsa D2 ho motho tse kenyeletsang molomong oa molomo oa KB220Z. Ba boetse ba fetisa maikutlo a hore ho eketseha ha li-receptor tsa D2 ka lehlakoreng le leng ho tla etsa hore ho be le boitšoaro bo kang ba litakatso tse kang lithethefatsi. Qetellong, mehopolo ena e emetse lithuto tse inahaneloang tsa neuro bakeng sa ho netefatsoa. Khabareng lithuto tsa morao-rao li ka hlahisa leseli le lecha le mekhoa e meng ea kalafo e teng [94].

Liphetho tse ntle tse bonts'itsoeng ke lipalo tse fokotsang tsa elektroencephalographic (qEEG) tlhahlobo-leseling e sa sebetseng, e buloang ka makhetlo a mararo e amanang le molomo e bontšitse keketseho ea maqhubu a alpha le ketsahalo e tlase ea beta sebakeng sa boko ba parietal. Re sebelisa lipalo-palo, phapang e kholo e hlokometseng lipakeng tsa placebo vs KB220Z e ile ea hlaha libakeng tse ka pele bekeng ea pele, 'me ea boela ea hlalosoa habeli ka beke ea bobeli.Setšoantšo sa 1)

Setšoantšo sa 1  

E bontša karabelo e ntle ho KB220Z ha e bapisoa le placebo ho lithuto tse laoloang tse sa sebetseng tse tsamaeang ka makhetlo a mararo tse sa bonahaleng ho basomi ba psychostimulant ba ntseng ba tsoela pele ho ithiba (ba fetotsoe ho Blum et al. [94]

Mehopolo ea ho buuoa ka Bariatric ho Karabelo ea Keketseho ea Tlhabollo ea Bokhoba ba Lithethefatsi (Cross-Tolerance)

Litlhahlobo tse phethahetseng tsa 'mele le kelello tsa pele ho ts'ebetso tse kopantsoeng le tlhokomelo e tsoelang pele ea bongaka le tlhabollo ka mor'a ts'ebetso li bohlokoa bakeng sa ho netefatsa sephetho se nepahetseng ho bakuli ba etsang opereishene ea bariatric. Bakuli ba ka 'nang ba lahleheloa ke boima ba' mele ba ka ba le nalane ea nakong e fetileng kapa ea hona joale ea mathata a fapaneng a bophelo bo botle ba kelello, ho kenyelletsa ho ja kapa ho lemalla joala, joala, lithethefatsi kapa lintho tse ling tse seng molaong; ts'ebeliso e mpe ea lithethefatsi e sebelisoang hangata e nkuoa e le lebaka la ho khetholla mokuli ho buoa. Leha ho le joalo, lenaneo la tlhahlobo ea pele ho ts'ebetso ea ts'ebetso ea ts'ebetso e ka thusa ho khetholla batho ba anngoeng ke mathata a joalo le ho ba lumella ho fumana kalafo e le hore ba ka hlola temallo eo mme ba shebane le ts'ebetso ea ho fokotsa boima ba 'mele nakong e tlang.

Ts'ebetso ea ho hlaphoheloa 'meleng ka mor'a ho buuoa ka bariatric le tlhoko ea ho ikamahanya le liphetoho tse kholo tsa bophelo tse latelang ts'ebetsong li baka khatello ea maikutlo. Anstrom et al. [98] e fumane hore lintoa tse mabifi ho likhoto tse hlotsoeng li amahanngoa le keketseho ea phetiso ea phasic dopamine tseleng ea mesolimbic e bonts'a karolo ea khatello ho phetisetso ea dopamine [98]. Kaha hoa tsebahala hore khatello ea maikutlo e fokotsa neuronal dopamine [98] hoa utloahala hore bakuli ba ka ba le mathata a boits'oaro a potlakileng kapa ba ntlafatsa boits'oaro e le karabelo mathateng ao ha ho ikoalla ho feta tekano e se e se khetho. Ha e le hantle ho boetse ho na le lipatlisiso tse fanang ka maikutlo a hore batho ba kileng ba etsa kalafo ea kalafo ea kalafo ea nakong e fetileng kapa likeletso tse ling bakeng sa boits'oaro bo bobebe ba ka sebetsa hantle haholo ka mor'a ho ikoetlisa ka boima ba 'mele kaha ba se ba ithutile mekhoa e metle ea ho sebetsana le bothata ba ho sebetsana le bothata.

Mang kapa mang ea etsang qeto ea lenaneo la bongaka la bariatric o lokela ho nahana ka ho fumaneha ha lits'ebeletso tse shebaneng le ho matlafatsa bophelo ba kelello. Litsebi tsa kelello / litsebi tsa kelello tse inehetseng ho bakuli ba buoang bakariatric ke karolo ea bohlokoa ea sehlopha sa bongaka se hlokahalang. Ntle le karolo ea bona ea tlhahlobo ea pele ho ts'ebetso, ba lula ba ikamahanya le bakuli kamora ho buuoa, e ba lumellang ho araba lipotso, ho fana ka kalafo le tšehetso le ho khetholla litloaelo life kapa life tse mpe tse hlahang le tlhoko ea ho kenella ho thibela phetoho ea bothata bo bohlokoa. .

Ho buuoa ka Bariatric ke mokhoa o fetolang bophelo le o ka 'nang oa pholosa bophelo, empa batho ba nahanang ts'ebetso ena ea ts'ebetso ea botona ho hlokahala hore ba rutehe ka botlalo ka likotsi tse ka ba teng mme ba itokisetse mathata ao ba tla thulana le ona hamorao. Keletso e tsoelang pele le ho nka karolo mesebetsing ea sehlopha sa tšehetso ho ka thusa ho tiisa bophelo bo botle ba maikutlo le ho thusa bakuli ho theha maano a ho sebetsana ka katleho le ona. Batho ka bomong ba sebelisang mananeo ana ho etsa liphetoho tse hlokahalang mekhoeng ea bona ea bophelo le litloaelo tsa ho ja ba tla sebeletsoa hantle, eseng feela ho fokotsa kotsi leha e le efe ea ho ba le mathata a boits'oaro a boits'oaro bo matla, empa ba eketsa menyetla ea bona ea sephetho se atlehileng ka kakaretso kamora ho buuoa ka bariatric.

Khokahanyo ea botenya - joala

Ha ho makatse hore ebe ho na le khokahano lipakeng tsa botena le botahoa United States le lefats'e. Ehlile sehokela se lula liphatseng tsa lefutso karolong e lebisang tšebetsong ea hypodopaminergic makaleng a meputso ea boko. Ho rua hoa botenya99e pakeng tsa 40-70% le bokhoba ba tahi [100e pakeng tsa 30-47% ka tatellano.

Keketseho ea botona bo holimo United States e imenne habeli lilemong tse mashome a mararo tse fetileng, ho tloha ho 15% ka 1976-1980 ho isa ho 33% ka 2003–2004 [101]. Ka mokhoa o ts'oanang, ho bile le keketseho e kholo menyetla ea ho shoa pele ho nako ka lebaka la lefu le amanang le botenya, mme tlatsetso e lekanyelitsoeng ea lefu le bakiloeng ke ho ba le lefu le tlisoang ke lefu la United States le eketsehile haholo lipakeng tsa 1990 le 2000 [102,103].

Har'a lintho tse ka kenyang kotsi ea ho ba kotsing ea ho ja ho feta tekano tikolohong e atileng ke ho haella ha taolo ea tšusumetso, mohlomong e amanang le phapang ea kutloisiso ea moputso oa neurochemical. Litšusumetso tse susumetsang, tse qobelloang le tse tlatsetsang ke litšoaneleho tsa tšebeliso ea lithethefatsi, le litloaelo tsa boits'oaro le tsa neurobiological lipakeng tsa botenya bo amanang le ho nona haholo le mathata a ts'ebeliso ea lithethefatsi li tlalehiloe lilemong tsa morao tjena mme li reiloe Reward Defence syndrome [30]. Mathata a ts'ebeliso ea lithethefatsi le botenya bo amanang le ho ja haholo li rarahane ebile li khona ho atiseha habonolo; ka bobeli li susumetsoa ke ho fumaneha le phihlello ea lintho tse matlafatsang haholo (joalo ka lithethefatsi kapa lijo tse fumanehang habonolo) ka bobeli li matlafatsoa ke khatello ea maikutlo, 'me ka bobeli li lebisa ho dopamine-moduction feto-fetoha ea neurobiological [104]. Boithuto bo hlokolosi le ba laboratori bo sibolotse khokahano lipakeng tsa litšobotsi tse hohelang le ho nona ho feta tekano, le khetho ea lijo tse fumanehang habonolo (mohlala, lijo tse monate, tse letsoai kapa tse mafura). Ka hona, hoa utloahala hore batho ba kotsing ea tšebeliso ea lithethefatsi ba anngoe ka mokhoa o fapaneng ke koluoa ​​ea botena ho United States [105,106].

Haufinyane tjena, Grucza et al. [107] ba lekolotse kamano lipakeng tsa botenya le botahoa United States mme ba fumana hore ka 2001-2002, basali ba nang le nalane ea lelapa ea tahi (e hlalosoang e le ho ba le motsoali oa tlhaho kapa ngoan'eno ea nang le nalane ea joala kapa mathata a joala) ba na le mathata a fetang 49%. ea ho ba le botenya ho feta ba se nang nalane ea lelapa (li-ratio, 1.48; 95% karohano ea boits'epo, 1.36-1.61; P <.001), keketseho e kholo haholo (P <.001) ho tloha ho karolelano ea likarolo tsa 1.06 (95% karohano ea boits'epo, 0.97-1.16) e hakantsoeng ka 1991-1992. Bakeng sa banna ka 2001-2002, mokhatlo o ne o le bohlokoa (karolelano ea likarolo, 1.26; 95% karohano ea boits'epo, 1.14-1.38; P <.001) empa e se matla joalo ka basali. Grucza et al. [107] o khothalelitse hore liphetho tsa bona li fana ka tšehetso ea lefu la setho se pakeng tsa kotsi ea joala ea malapa le botenya ho basali mohlomong le ho banna. Khokahano ena e hlahile lilemong tsa morao tjena mme e ka hlaha ka lebaka la tšebelisano lipakeng tsa tikoloho e fetohang ea lijo le ho tsilatsila ho joala le mathata a amanang le ona.

fihlela qeto e

Ho nona ke lefu la seoa le ntseng le hola lefats'eng la bophirimela ebile le hlaha e le lefu le fokolisang ka ho fetisisa mehleng ea kajeno, hammoho le sesosa se ka sehloohong sa lefu le ka thibeloang. Ho buoa bakariatric, kapa ho buoa boima ba 'mele, ho kenyelletsa mekhoa e mengata e sebelisoang ho batho ba batenya haholo. Ho buuoa ka Bariatric ho etselitsoe lithuto tse nang le BMI ≥ 40 kg / m (2) kapa ≥ 35 kg / m (2) ka li-co-morbidities

Liphuputso tse 'maloa tsa morao-rao li tlaleha ho fokotseha ha lefu le ho teba ha maemo a bongaka ka mor'a ho buuoa ka bariatric. Boithuto ba nako e telele bo bonts'a lits'ebetso li baka tahlehelo ea boima ba nako e telele, ho fola, lefu la tsoekere, ntlafatso ea maemo a pelo le phokotseho ea ho shoa hoa batho ba 23% ho tloha ho 40%. Empa leha ho le joalo kamora lilemo tse ngata tsa lingaka tse buoang tse sebetsanang hantle tsa bongaka li hlokometse ebile li tlaleha ntho e ncha: hore bakuli ba bang ba nkela khatello e tlisoang ke tlhekefetso ka mathata a macha a qobelloang le a bokhoba.

Ho nona haholo le botenya li ka sebetsa e le lintho tse sirelletsang ho fokotsa moputso oa lithethefatsi, le boits'oaro bo tlatsetsang ka mohlomong ka lebaka la ho ts'oana ho tloaelehileng ha methapo ea kutlo. Mefuteng ea liphoofolo tse lemalloang ho khaotsa ho se leka-lekane ha tsoekere ho etsang hore motho a se ke a leka-lekana ho acetylcholine le dopamine e tšoanang le ho ikhula. Lithuto tse ngata tsa batho tse nang le phepo e matla li tšehelitse mohopolo oa ho hokela takatso ea lijo le boitšoaro ba ho lakatsa lithethefatsi.

Pejana laboratori ea rona e ne e qalile polelo ea RDS mme e tlaleha hore boleng ba ponelopele bakeng sa boits'oaro ba RDS nakong e tlang lithutong tse nang le DRD2 Taq A1 allele e ne e le 74%. Le ha liphatsa tsa lefutso li bapala karolo ho RDS, re boetse re hlahisitse hore ho sitisoa ha ts'ebetso ea dopamine ho ka etsa hore batho ba bang ba be le boits'oaro bo bobebe le botena. Ha joale hoa tsebahala hore nalane ea malapa ea botaoa ba joala ke eona ntho e bohlokoa e ka bakang botenya. Ka hona, re ts'episa hore RDS ke sesosa sa ho fetisetsa lekhoba la lijo bakeng sa litlhokahalo tse ling mme ka mokhoa o hlalosang ketsahalo ena e ncha e tloaelehileng kamora ts'ebetso ea bongaka ea bariatric.

lumela hore baa fokola

Ho ngoloa ha pampiri ena ho ne ho tšehelitsoe ke karolo ea NIAAA lithuso R01 AA 07112 le K05 AA 00219), le Lefapha la Patlisiso ea bongaka la VA ho ea MO-B.

Bangoli ba leboha litlhaloso le liphetoho tsa Margaret Madigan. Bangoli ba leboha graph e fanoeng ke Margaret Madigan. Re leboha thuso ea tlhahiso le tlhahiso ea Uma Damle. Re tlameha ho leboha tlhabollo ea tlaleho ea nyeoe e fanoeng ke Siobhan Morse oa G & G Holistic Addiction Treatment Center, North Miami Beach, Florida. Buka ena e ngotsoeng ka letsoho qalong e bululetsoe ke Dr. Roger Waite.

Mongolo o botlaaseng ba leqephe

Ena ke sehlooho se bulehileng sa ho finyelloa tlas'a melao ea License ea Creative Commons Attribution, e lumellang hore ho sebelisoe, ho abeloa le ho thibela ho thibela mekhoa eohle, ho fana ka moqolo le mohloli oa pele.

 

Khohlano ea Thahasello

Kenneth Blum, PhD e na le litokelo tsa molao tse amanang le KB220Z mme o file LifeGen, Inc, San Diego, California ka litokelo tse ikhethileng lefatšeng ka bophara. Kenneth Blum o na le stock ho LifeGen, Inc. John Giordano ke molekane oa Lifegen, Inc. Ha ho na sengoli se seng se bolelang hore ho na le khohlano ea phaello.

References

1. Robinson MK. Kalafo ea ho buoa ea botenya - ho lekanya lintlha. N Engl J Med. 2009;361: 520-521. [E fetotsoe]
3. Odom J, Zalesin KC, Washington TL, Miller WW, Hakmeh B, et al. Bathuli ba boitšoaro bo botle ba ho khutla hape ka boima ba 'mele ka mor'a ho buuoa ka bariatric. Mabaka Surg. 2010;20: 349-356. [E fetotsoe]
4. Chiles C, van Wattum PJ. Likarolo tsa kelello tsa koluoa ​​ea botenya. Linako tsa Psychiatr. 2010;27l: 47-51.
5. Sjöström L, Narbro K, CD ea Sjöström, Karason K, Larsson B, et al. Litlamorao tsa ho buuoa ka bariatric ho lefu la baithuti ba li-Sweden tse fetang tekano. N Engl J Med. 2007;357: 741-752. [E fetotsoe]
6. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, et al. Mafu a nako e telele kamora ho buuoa ka gastric bypass. N Engl J Med. 2007;357: 753-761. [E fetotsoe]
7. O'Brien Paul E, Dixon John B, Laurie Cheryl, Skinner Stewart, Proietto Joe, et al. Phekolo ea Monate ho Bonolo ho Feta Tekano le Laparoscopic Adaptable Gastric Banding kapa lenaneo le matla la bongaka. Annals of Internal Medicine. 2006;144: 625-633. [E fetotsoe]
8. Colquitt JL, Picot J, Lerato E, Clegg AJ. Ho buuoa ka botenya 2009
10. Hazzan D, Chin EH, Steinhagen E, Kini S, Gagner M, et al. Ho buuoa ka Laparoscopic bariatric ho ka ba kotsi bakeng sa kalafo ea botenya bo feteletseng ho bakuli ba lilemo tse fetang 60. Surg Obes Rekisa Dis. 2006;2: 613-616. [E fetotsoe]
11. Flum DR, Belle SH, King WC, Wahed AS, et al. Tlhahlobo ea nako e telele ea Consortium ea Bariatric (LABS) Consortium. Polokeho ea ts'ebetso ho liteko tse telele tsa ho buuoa ka bariatric. N Engl J Med. 2009;361: 445-454. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
12. Snow V, Barry P, Fitterman N, Qaseem A, Weiss K. Pharmacologic le ts'ebetso ea ts'ebetso ea botena ho tlhokomelo ea mantlha: tataiso ea tlhahlobo ea bongaka e tsoang Koleji ea Amerika ea Lingaka. Ann Intern Med. 2005;142: 525-531. [E fetotsoe]
13. Buchwald H, Rudser KD, Williams SE, Michalek VN, Vagasky J, et al. Kakaretso ea lefu la motho, nako ea bophelo bo eketsehang, le sesosa sa lefu ka lilemo tse 25 lenaneong la taolo ea ts'ebetso ea ts'ebetso ea methapo. Ann Surg. 2010;251: 1034-1040. [E fetotsoe]
14. Moreno Esteban B, Zugasti Murillo A. Bariatric surge: ntjhafatso. Rev Med Univ Navarra. 2004;48: 66-71. [E fetotsoe]
15. Wendling A, Wudyka A. Narcotic Addiction Ho latela Gastric Bypass Surgery-Case Study. Mabaka Surg. 2011;21: 680-683. [E fetotsoe]
16. Acosta MC, Manubay J, Levin FR. Ho ba mothating oa bongaka ba bana: li tsamaellana le litlhahiso le litlhahiso tsa kalafo. Harv Rev Psychiki. 2008;16: 80-96. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
17. Sogg S. Ts'ebeliso e mpe ea joala kamora ho buuoa ka bariatric: pheniponomenon kapa ntho ea "Oprah"? Surg Obes Rekisa Dis. 2007;3: 366-368. [E fetotsoe]
18. James GA, Gold MS, Liu Y. Ho sebelisana ha satiety le karabelo ea moputso ho khothalletso ea lijo. J Khotso Dis. 2004;23: 23-37. [E fetotsoe]
19. McIntyre RS, McElroy SL, Konarski JZ, Soczynska JK, Bottas A, et al. Mathata a ts'ebeliso ea lithethefatsi le botenya / botena bo feteletseng ho lefu la ho ferekana kelellong: bopaki ba pele ba ho tsekisana. J Clinic Psychiatry. 2007;68: 1352-1357. [E fetotsoe]
20. Kleiner KD, Gold MS, Frost-Pineda K, Lenz-Brunsman B, Perri MG, et al. Lenane la boima ba 'mele le tšebeliso ea joala. J Khotso Dis. 2004;23: 105-118. [E fetotsoe]
21. Hagedorn JC, Encarnacion B, Brat GA, Morton JM. Na gastric bypass e fetola metabolism ea joala? Surg Obes Rekisa Dis. 2007;3: 543-548. [E fetotsoe]
22. Spencer J. Saense e ncha ea bokhoba ba tahi: Botahoa ba batho ba neng ba buuoa ka boima ba 'mele bo fana ka leseli la hore na motho o tla tšepahala kapa che. Wall Street Journal 2006
23. Blum K, Giordano J, Morse S, et al. Tekolo ea kotsi ea kotsi ea lefutso (GARS): Tlhabollo e matla ea litlatsetso tsa kotsi ea polymorphic ho banna ba lemaletseng lithethefatsi feela. Sengolo sa IIOAB. 2010;1: 1-14.
24. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. Dopamine ts'ebelisong ea lithethefatsi le tšebeliso ea litlamorao: litlamorao tsa lithuto tsa ho nahana ka maikutlo le litlamorao tsa kalafo. Arch Neurol. 2007;64: 1575-1579. [E fetotsoe]
25. Wang GJ, Volkow ND, Thanos PK, Fowler JS. Ho tšoana pakeng tsa botenya le bokhoba ba lithethefatsi joalo ka ha ho hlahlojoa ke monahano oa neurofunctional: tlhahlobo ea mohopolo. J Khotso Dis. 2004;23: 39-53. [E fetotsoe]
26. Stice E, Yokum S, Blum K, Bohon C. Ho phahamisa boima ba 'mele ho tsamaisana le karabelo e fokotsehileng ea lijo tse fumanehang habonolo. J Neurosci. 2010;30: 13105-13109. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
27. Stice E, Yokum S, Bohon C, Marti N, Smolen A. Motsoako oa ho potoloha oa lijo ho hakanyetsang lijo o hakanya bokamoso ba boima ba 'mele: litlamorao tsa phetoho ea DRD2 le DRD4. Nako ea mokokotlo. 2010;50: 1618-1625. [E fetotsoe]
28. Stice E, Spoor S, Bohon C, DM e nyane. Kamano pakeng tsa botenya le karabelo e makatsang ea lijo li fetisoa ke TaqIA A1 allele. Saense. 2008;322: 449-452. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
29. Dunn JP, Cowan RL, Volkow ND, ID ea Bohloli, Li R, et al. Mofuta oa 2 oa phepelo ea dopamine e fokotsehileng ka mor'a ho buuoa ka bariatric: lipatlisiso tsa pele. Resin ea Boko. 2010;1350: 123-130. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
30. Blum K, Cull JG, Braverman ER, Comings DE. Moputso Disability Syndrome. Rasaense oa Amerika. 1996;84: 132-145.
31. Liu Y, von Deneen KM, Kobeissy FH, Gold MS. Tlatsetso ea lijo le botenya: bopaki bo tsoang bencheng ho ea betheng. J Psychoactive Drugs. 2010;42: 133-145. [E fetotsoe]
32. Warren MW, Khauta ea MS Gold. Kamano lipakeng tsa botenya le tšebeliso ea lithethefatsi. Am J Psychiatry. 2007;164: 1268-1269. [E fetotsoe]
33. Kalarchian MA, Marcus MD, Levine MD, Courcoulas AP, Pilkonis PA, et al. Mathata a kelello mahareng a bakuli ba buoang ka bariatric: kamano ea botenya le boemo bo botle ba bophelo. Am J Psychiatry. 2007;164: 328-334. [E fetotsoe]
34. Morgenson GL. Boithuto ba li-nucleus accumbens le meslimbic dopaminergic ea eona e ama kameho le boits'oaro ba ingestive le moputso. Ho: Hoebel GB, Novel D, bahlophisi. Motheo oa neolo oa ho fepa le moputso. Brunswick. ME: Setsi sa Haer;
35. Comings DE, Flanagan SD, Dietz G, Muhleman D, Knell E, et al. Dopamine D2 receptor (DRD2) e le mofuta o ka sehloohong oa botena le bophahamo. Biochem Med Metab Biol. 1993;50: 176-185. [E fetotsoe]
36. Comings DE, Gade R, MacMurray JP, Muhleman D, Peters WR. Mefuta e fapaneng ea lefutso la botena ba motho (OB): ho kopana le index ea boima ba 'mele ho basali ba banyane, matšoao a kelello, le ho sebelisana le mofuta oa dopamine D2 receptor (DRD2). Mol Psychiatry. 1996;1: 325-335. [E fetotsoe]
37. Noble EP, Noble RE, Ritchie T, Syndulko K, Bohlman MC, et al. D2 dopamine receptor gene le botenya. Int J Dis Disord. 1994;15: 205-217. [E fetotsoe]
38. Barnard ND, Noble EP, Ritchie T, Cohen J, Jenkins DJ, et al. D2 dopamine receptor Taq1A polymorphism, boima ba 'mele, le ho ja lijo tse nang le lefu la tsoekere la mofuta oa 2. Phepo e nepahetseng. 2009;25: 58-65. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
39. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, et al. Dopamine D2 mefuta ea li-receptor: mefuta ea ho hokahana le ho hokahana ka boitsoaro bo sa qhekelleheng. Pharmacogenetics. 1995;5: 121-141. [E fetotsoe]
40. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Mokhatlo o hlophisitsoeng oa liphatsa tsa lefutso tsa D2 dopamine receptor tse nang le litšobotsi tse tlamang ka tahi. Arch Gen Psychiatry. 1991;48: 648-654. [E fetotsoe]
41. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, et al. Dopamine ea boko le botenya. Lancet. 2001;357: 354-357. [E fetotsoe]
42. Volkow ND, Wang GJ, Tomes 'D, Telang F, Fowler JS, et al. Methylphenidate e bonts'a tšitiso ea kelello ea "limbic brain" kamora ho pepesetsoa ha batho ba sebelisang koae. PLoS One. 2010;5: e11509. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
43. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, et al. Tekanyo e tlase ea li-dopamine D2 receptors ho bahlaseli ba methamphetamine: setsoalle le metabolism ho cortex ea orbitofrontal. Am J Psychiatry. 2001;158: 2015-2021. [E fetotsoe]
44. Blum K, Braverman ER, Wood RC, Gill J, Li C, et al. Keketseho e atileng ea Taq I A1 allele ea dopamine receptor gene (DRD2) bothateng bo feteletseng bo nang le bothata ba tšebeliso ea lithethefatsi tsa comorbid: tlaleho ea pele. Pharmacogenetics. 1996;6: 297-305. [E fetotsoe]
45. Davis CA, Levitan RD, Reid C, Carter JC, Kaplan AS, et al. Dopamine bakeng sa "ho batla" le li-opioids tsa "ho rata": papiso ea batho ba baholo ba batenya le ba sa jang ka letho. Botenya 2009;17: 1220-1225. [E fetotsoe]
46. Bohon C, Stice E. Moputso o sa tloaelehang ho basali ba nang le botlalo le bohloeki ba bulimia mothosa: Thutong ea maiketsetso e sebetsang. Int J Eat Disord 2010 [Tlhahiso ea mahala ea PMC] [E fetotsoe]
47. Jimerson DC, Wolfe BE, Carroll DP, Keel PK. Psychobiology ea bothata ba ho hloekisa: ho fokotseha hoa litekanyetso tsa leptin ho lefu la ho hloekisoa ha ho bapisoa le taolo. Int J Dis Disord. 2010;43: 584-588. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
48. Zhang Y, Smith EM, Baye TM, Eckert JV, Abraham LJ, et al. Mefuta e meng ea tatellano ea 5c ea Moses Serotonin (5-HT) e ama maemo a triglyceride ea motho. Physiol Genomics. 2010;42: 168-176. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
49. Kring SI, Werge T, Holst C, Toubro S, Astrup A, et al. Li-polymorphisms tsa mofuta oa serotonin receptor 2A le 2C le COMT mabapi le botena le lefu la tsoekere la mofuta oa 2. PLoS One. 2009;4: e6696. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
50. Erritzoe D, Frokjaer VG, Haugbol S, Marner L, Svarer C, et al. Brain serotonin 2A receptor e tlamang: likamano ho index ea mmele, koae le tšebeliso ea joala. Nako ea mokokotlo. 2009;46: 23-30. [E fetotsoe]
51. Hammer C, Kapeller J, Endele M, Fischer C, Hebebrand J, et al. Mefuta e sebetsang ea mofuta oa serotonin receptor mofuta oa 3A le B e amana le mathata a ho ja. Pharmacogenet Genomics. 2009;19: 790-799. [E fetotsoe]
52. Vucetic Z, Kimmel J, Totoki K, Hollenbeck E, Reyes TM. Matšoao a amanang le phepo e phahameng ea bo-'mè a fetolang lijo tse nang le phepo e phahameng ea 'mele le polelo ea mofuta oa genopamine le liphatsa tsa lefutso tse amanang le opioid. Endocrinology. 2010;151: 4756-4764. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
53. Xu L, Zhang F, Zhang DD, Chen XD, Lu M, et al. Mofuta oa OPRM1 o amahanngoa le BMI ho palo ea Uyghur. Botenya 2009;17: 121-125. [E fetotsoe]
54. Zuberi AR, Townsend L, Patterson L, Zheng H, Berthoud HR, et al. Keketseho e kholo ea phepo e tloaelehileng, empa e fokotsehe habonolo ea ts'ebeliso ea botenya ho litoeba tsa "mu-opioid receptor" tse haelloang ke phepo. Eur J Pharmacol. 2008;585: 14-23. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
55. Tabarin A, Diz-Chaves Y, Carmona Mdel C, Catargi B, Zorrilla EP, et al. Ho hanela botenya bo khothalletsoang ke ho ja lijong tse haelloang ke phepo e ntle ea "muine opioid receptor": bopaki ba "mofuta o atlehileng" Lefu la tsoekere. 2005;54: 3510-3516. [E fetotsoe]
56. Kelley AE, Bakshi VP, Haber SN, Steininger TL, Will MJ, et al. Opioid modulation ea tatso hedonics kahare ho ventral striatum. Physiol Behav. 2002;76: 365-377. [E fetotsoe]
57. Vucetic Z, Kimmel J, Totoki K, Hollenbeck E, Reyes TM. Matšoao a amanang le phepo e phahameng ea bo-'mè a fetolang lijo tse nang le phepo e phahameng ea 'mele le polelo ea mofuta oa genopamine le liphatsa tsa lefutso tse amanang le opioid. Endocrinology. 2010;151: 4756-4764. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
58. Lucignani G, Panzacchi A, Bosio L, Moresco RM, Ravasi L, et al. Gaba Tlhatlhobo ea receptor ho Prader-Willi e hlahlojoa ka positron emission tomography le [11C] flumazenil. Nako ea mokokotlo. 2004;22: 22-28. [E fetotsoe]
59. Boutin P, Dina C, Vasseur F, Dubois S, Corset L, et al. GAD2 ho chromosome 10p12 ke mofuta oa khetho ea botena ba motho. PloS Biol. 2003;1: E68. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
60. Rosmond R, Bouchard C, Björntorp P. Allelic variants ho GABA (A) alpha6 receptor subunit gene (GABRA6) e amana le botenya ba mpa le secretion ea cortisol. Int J Obes Relat Disab Disord. 2002;26: 938-941. [E fetotsoe]
61. Li CY, Mao X, Wei L. gen le (mekhoa e tloaelehileng) e tlisoang ke bokhoba ba lithethefatsi. PloS Comput Biol. 2008;4: e2. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
62. Salamone JD, Cousins ​​MS, Snyder BJ. Mesebetsi ea boits'oaro ea li-nucleus accumbens dopamine: mathata a kelello le a kelello a nang le anhedonia hypothesis. Neurosci Biobehav Rev. 1997;21: 341-359. [E fetotsoe]
63. Stice E, Spoor S, Ng J, Zald DH. Kamano ea botena ho moputso le lijo tse lebelletsoeng. Physiol Behav. 2009;97: 551-560. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
64. Meguid MM, Fetissov SO, Varma M, Sato T, Zhang L, et al. Hypothalamic dopamine le serotonin molaong oa phepelo ea lijo. Phepo e nepahetseng. 2000;16: 843-857. [E fetotsoe]
65. Baskin DG, Figlewicz Lattemann D, Seeley RJ, Woods SC, Porte D, Jr, et al. Insulin le leptin: lipontšo tse tsamaeang le maemo a mabeli ho ea bokong bakeng sa taolo ea lijo le boima ba 'mele. Resin ea Boko. 1999;848: 114-123. [E fetotsoe]
66. Blum K, Gold MS. Ts'ebetso ea ts'ebetso ea lik'hemik'hale ea Neuro ea ts'ebetso ea moputso oa boko o phaellanang le litho tsa "circic" li amana le thibelo ea ho khutla le tlala ea lithethefatsi: Hypothesis. Hypotheses tsa bongaka. 2011;76: 576-584. ka khatiso. [E fetotsoe]
67. Bayol SA, Simbi BH, Fowkes RC, Stickland NC. Lijo tsa "lijo tse se nang phepo" tsa bo-mme nakong ea bokhachane le ho nyekeloa ke mpa li khothaletsa lefu la sebete se sa amaneng le joala ho bana ba likhoto. Endocrinology. 2010;151: 1451-1461. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
68. Blum K, MS Khauta. Ntho-lik'hemik'hale tsa lik'hemik'hale tsa boko bo botle-li-limbic tsa potoloho li amahanngoa le ho thibela ho khutla le ho lapa lithethefatsi: khopolo-taba. Tšoaea liphoso. 2011;76: 576-84. [E fetotsoe]
69. Blumenthal DM, Gold MS. Neurobiology ea temallo ea lijo. Mokhatlo oa Curr Opin oa Meriana ea Meriana ea Meriana. 2010;13: 359-365. [E fetotsoe]
70. Avena NM, Carrillo CA, Needham L, Leibowitz SF, Hoebel BG. Lirata tse itšetlehileng ka tsoekere li bonts'a tšebeliso e matlafatsang ea ethanol e sa koaeloang. Joala. 2004;34: 203-209. [E fetotsoe]
71. Cantin L, Lenoir M, Augier E, Vanhille N, Dubreucq S, et al. Cocaine e tlase lenaneng la boleng ba litoeba: bopaki bo ka ba teng ba ho mamella le ho lemalla. PLoS One. 2010;5: e11592. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
72. Koob GF, Le Moal M. Plasticity ea moputso oa neurocircuitry le 'lehlakore le lefifi' la bokhoba ba lithethefatsi. Nat Neurosci. 2005;8: 1442-1444. [E fetotsoe]
73. Avena NM, Bocarsly ME, Rada P, Kim A, Hoebel BG. Kamora ho itlopa joala letsatsi le letsatsi ka tharollo ea sucrose, khaello ea lijo e etsa hore motho a tšoenyehe 'me e be le ho leka-lekana ha dopamine / acetylcholine. Physiol Behav. 2008;94: 309-315. [E fetotsoe]
74. Wilson GT. Mathata a ho ja, botenya le ho lemalla. Sejo sa Ts'ebetso sa E-ja Rev. 2010;18: 341-345. [E fetotsoe]
75. Bennett C, sinatra S. Lefu la tsoekere! New York: Sehlopha sa Penquin; 2007.
76. Gold MS, Graham NA, Cocores JA, Nixon S. Tlatsetso ea Lijo? Tlaleho ea bongaka ba tlatsetso. 2009;3: 42-45. [E fetotsoe]
77. Downs BW, Chen AL, Chen TJ, Waite RL, Braverman ER, et al. Morero oa Nutrigenomic oa ts'ebetso ea takatso ea nama ea nama ea nama ea kolobe: na re ka khona ho laola boits'oaro bo bobe le boits'elo bo tsosang takatso ka ho laola tsela ea methapo ka methapo ea lintho tse amanang le phepo e ntle ea 'mele (GMN)? Tšoaea liphoso. 2009;73: 427-434. [E fetotsoe]
78. Gearhardt AN, Corbin WR, Brownell KD. Tlhatlhobo ea pele ea Naleli ea Tlatsetso ea Lijo ea Yale. Takatso ea lijo. 2009;52: 430-436. [E fetotsoe]
79. Ifland JR, Preuss HG, Marcus MT, Rourke KM, Taylor WC, le al. Ho lemalla lijo tse lekaneng: mokhoa o tloaelehileng oa ho sebelisa lithethefatsi. Tšoaea liphoso. 2009;72: 518-26. [E fetotsoe]
80. Pelchat ML. Tlatsetso ea lijo ho batho. J Nutr. 2009;139: 620-622. [E fetotsoe]
81. Avena NM. Thutong ea bokhoba ba lijo ka ho sebelisa mefuta ea liphoofolo ea ho itlopa lijo. Takatso ea lijo 2010 [E fetotsoe]
82. Avena NM, Kobaissy FH, Bocarsly ME, Yang M, Hoebel BG. Ho itlopa joala ho etsa hore ho be le mofuta o mong oa ts'ebeliso e mpe ea lithethefatsi. Poster
83. Blum K, Kozlowski GP. Tšebelisano ea Ethanol le neuromodulator: mohlala oa moputso oa papali ea bohlasoa. Ka: Ollat H, Parvez S, Parvez H, bahlophisi. Joala le Boitšoaro. Utrecht, Netherlands: VSP Press; 1990. maq. 131-149.
84. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ. Mofuta oa D2 dopamine receptor e le sesupo sa khaello ea moputso. R Soc Med. 1996;89: 396-400. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
85. Kirsch P, Reuter M, Mier D, Lonsdorf T, Stark R, et al. Litšebelisano tsa ho ts'oara liphatsa tsa lefutso: litlamorao tsa polymorphism ea DRD2 TaqIA le dopamine agonist bromocriptine ts'ebetsong ea boko nakong ea ho lebella moputso. Neurosci Lett. 2006;405: 196-201. [E fetotsoe]
86. Rothemund Y, Preuschhof C, Bohner G, Bauknecht HC, Klingebiel R, et al. Ts'usumetso e fapaneng ea dorsal striatum ke takatso e phahameng ea khalori ea lijo tse susumetsoang ke batho ba batenya. Nako ea mokokotlo. 2007;37: 410-421. [E fetotsoe]
87. Johnson PM, Kenny PJ. Dopamine D2 receptors ka ho lemalla ho lemalla ho lemala le ho qobella ho ja likhoto tse ngata. Nat Neurosci. 2010;13: 635-641. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
88. Cordeira JW, Frank L, Sena-Esteves M, Pothos EN, Rios M. Brain-based neurotrophic factor e laola phepo ea hedonic ka ho sebetsa tsamaisong ea mesolimbic dopamine. J Neurosci. 2010;30: 2533-2541. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
89. Lobo MK, Covington HE, Chaudhury D, Friedman AK, Sun H, et al. Tahlehelo ea mofuta o khethehileng oa taolo ea BDNF ea ho supa mimics optogenetic ea moputso oa koae. Saense. 2010;330: 385-390. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
90. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T. Allelic mokhatlo oa setho sa dopamine D2 receptor jwala. JAMA. 1990;263: 2055-2060. [E fetotsoe]
91. Piray P, Keramati MM, Dezfouli A, Lucas C, Mokri A. Phapang e ikhethang ea li-nucleus accumbens dopamine receptors e bolela tsoelo-pele ea boits'oaro bo joalo ba ts'ebeliso: mokhoa oa ho kopanya. Khomphutha ea Neural. 2010;22: 2334-2368. [E fetotsoe]
92. Comings DE, Blum K. Reward syndrome ea bofokoli: likarolo tsa liphatsa tsa lefutso. Prog Brain Res. 2000;126: 325-341. [E fetotsoe]
93. Bowirrat A, Oscar-Berman M. Kamano e teng pakeng tsa ho thibela mali, ho noa joala, le bothata ba ho ba le bothata ba ho ba le mpho. Am J Med Genet B Neuropsychiatr Genet. 2005;132: 29-37. [E fetotsoe]
94. Blum K, Chen TJ, Morse S, Giordano J, Chen AL, et al. Ho hlola litlolo tsa qEEG le ho putsa bofokoli ba liphatsa tsa lefutso nakong ea ho itšireletsa ho ts'ebetso ea kelello ho banna psychostimulant le bahlaseli ba polydrug ba sebelisang dopamine D ea ho beha2 Phekolo ea agonist: karolo ea 2. Postgrad Med. 2010;122: 214-26. [E fetotsoe]
95. Rothman RB, Blough BE, Baumann MH. Daptamine tse peli tsa dopamine / serotonin e le meriana e ka bang teng mokhoeng oa ho khothaletsa joala le joala. Mokhatlo oa AAPS J. 2007;9: E1–10. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
96. Lawford BR, RM e Nyane, Rowell JA, Qualichefski J, Fletcher BH, et al. Bromocriptine kalafong ea lino tse tahang le D2 dopamine receptor A1 allele. Nat Med. 1995;1: 337-341. [E fetotsoe]
97. Brandacher G, Winkler C, Aigner F, Schwelberger H, Schroecksnadel K. Ho ikoetlisa ka bongaka ha ho khone ho thibela ho fokola hoa mmele ka lebaka la ts'ebetso e sa foleng ea ts'ireletso ea mmele ho bakuli ba boitšoaro bo hlephileng. Mabaka Surg. 2006;16: 541-548. [E fetotsoe]
98. Anstrom KK, Miczek KA, Budygin EA. Keketseho ea phasic dopamine e bontšang tseleng ea mesolimbic nakong ea ho hloloa hoa sechaba ka likhoto. Khopolo-taba. 2009;161: 3-12. [E fetotsoe]
99. Yazbek SN, Spiezio SH, Nadeau JH, Buchner DA. Ancestral paternal genotype e laola boima ba 'mele le lijo tse matlafatsang meloko e mengata. Hum Mol Genet. 2010;19: 4134-4144. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
100. Sartor CE, Agrawal A, Lynskey MT, Bucholz KK. Litšusumetso tsa lefutso le tikoloho ka sekhahla sa tsoelo-pele ea kholiseho ea joala ho basali ba banyane. Alcohol Clinic Exp Res. 2008;32: 632-638. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
101. Ogden CL, Carroll MD, McDowell MA, Flegal KM. Ho nona haholo hara batho ba baholo United States: ha ho phetoho e kholo ea lipalo ho tloha 2003-2004. Kakaretso ea NCHS ea data. 2007;1: 1-8. [E fetotsoe]
102. Flegal KM, Graubard BI, Williamson DF, Gail MH. Lisosa tse khethehileng tsa lefu tse amanang le boima ba 'mele, boima bo feteletseng le botenya. JAMA. 2007;298: 2028-2037. [E fetotsoe]
103. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Lisosa tsa lefu United States, 2000. JAMA. 2004;291: 1238-1245. [E fetotsoe]
104. Volkow ND, RA ea Wise. Ho lemalla lithethefatsi ho ka re thusa joang hore re utloisise botenya Nat Neurosci. 2005;8: 555-560. [E fetotsoe]
105. Cocores JA, Gold MS. Sejo se Salted Li-Addiction Hypothesis li ka 'na tsa hlalosa ho ja lijo tse matlafatsang le botenya ba botenya. Tšoaea liphoso. 2009;73: 892-899. [E fetotsoe]
106. Davis C, Patte K, Levitan R, Reid C, Tweed S, et al. Ho tloha ho tšusumetso ho ea boits'oarong: mohlala oa maikutlo a moputso, ho nona ho feta tekano le khetho ea lijo sebakeng sa kotsi sa ho nona. Takatso ea lijo. 2007;48: 12-19. [E fetotsoe]
107. Grucza RA, Krueger RF, Racette SB, Norberg KE, Hipp PR, et al. Khokahano e hlahang pakeng tsa kotsi ea joala le botenya li United States. Arch Gen Psychiatry. 2010: 1301-1308. [Tlhahiso ea mahala ea PMC] [E fetotsoe]